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Abstract
Aim: This pilot study compared the efficacy of superficial dry needling (SDN), deep dry 
needling (DDN), placebo dry needling (PDN) and a common physiotherapy control group 
(CON) when used in the treatment of myofascial trigger points (MTrPs) in rotator cuff 
syndrome (RCS) patients.  
Methodology: A randomised, single-blind, placebo-controlled pilot study (n=20) was 
conducted comparing the three needling groups to each other and to a common 
physiotherapy protocol.  Participants were selected patients presenting for treatment in a 
private practice.  The objectives of the study were to compare the groups on three levels: 
Pre trial-Post trial, within individual treatment session (Intra-treatment), and between 
treatment sessions (Inter-treatment).  All groups were treated with the same basic common 
protocol but three of them had the addition of one each of the needling interventions.  A 
modified Constant-Murley scale, range of motion and power were used as outcomes 
measures.  Ethical permission was obtained from the University of the Witwatersrand.
Results: Results were analysed for the four groups using an ANCOVA.  DDN had 
significant improvement over CON over the trial period (p≤0.05) and SDN (p≤0.02).  This 
was particularly due to highly significant intra-treatment effect on internal range of motion 
at session 3 (p≤0.01) and the highly significant inter-treament effect between session 3 
and 4 (p≤0.03).   DDN was significantly less effective than the other groups at session 3 
(p≤0.01) and session 4 (p≤0.03).  External rotation power was also significantly greater for 
DDN between sessions 2 and 3 (inter-treatment) (p≤0.05).  49% of the MTrPs identified 
were found within the infraspinatus muscles.
 
Discussion: Twitch-obtaining dry needling (DDN) appears to show greater clinical benefit 
on the effects of myofascial trigger points than SDN, CON or PDN. The effect appears to 
correlate with the greater incidence of MTrPs in the infrapinatus muscles whose functions 
directly relate to the improved parameters.  The clinical effect may be related to the effects 
of the bleeding elicited by intramuscular needling (humoral effects).  This is evidenced by 
the transiently poor effect of DDN immediate following treatment becoming significanly 
better by the following treatment.
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Conclusion: The pilot study showed that DDN may be an effective treatment for RCS 
when used in conjunction with a conventional physiotherapy programme. The elicitation of 
a local twitch response and associated bleeding may be significant.  In future studies, 
particular attention should be paid to both the infraspinatus muscle and the timing of the 
intervention and observation intervals.
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1. INTRODUCTION 
1.1. BACKGROUND TO ROTATOR CUFF SYNDROME
One of the most common presentations of shoulder pain is that of a rotator cuff syndrome 
(RCS). The aetiology of RCS is enigmatic, but the syndrome classically presents with a 
combination of pain, loss of range of movement and decreased strength of the affected 
shoulder (Ferguson 2005). Bron et al (2007) reported the one-year prevalence of such 
pain to vary between 20% and 50%.  In a United Kingdom community-based prevalence 
study, shoulder pain (mixed diagnoses) ranked as the third highest cause of 
musculoskeletal pain (Urwin et al 1998).  There are no comparable figures for South 
Africa.  The South African physiotherapist’s scope of practice declares that 
physiotherapists are “primarily involved in the management of physical problems in 
particular those associated with neuromuscular, musculoskeletal, cardiovascular and 
respiratory systems” (Eales 2001:1).  However, evidence for the success of 
physiotherapeutic intervention in this high prevalence musculoskeletal disorder is weak 
(Mitchell et al 2005).
12 
Fig 1.1  The place of dry needling therapy in 
Physiotherapy
Biopsychosocial approach
|
Musculoskeletal 
treatment modalities
(Manual therapies, Exercise, 
Electrotherapy, Myofascial release)
 |
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 |
Trigger point 
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Dry 
needling
Much of the published research on physiotherapeutic treatment of RCS concerns exercise, 
joint mobilisation and electrotherapy (Green et al 2003).  Little is known about the 
contribution of myofascial sources for pain in RCS (Bron et al 2007).  Travell and Simons 
held that myofascial dysfunction can exist in a painful joint with or without structural 
abnormalities (Travell & Simons 1999).  The key element of such dysfunction is the 
phenomenon of the myofascial trigger point (MTrP) (Ingber 2003).  MTrPs have 
characteristic symptoms which mimic those found in RCS, but the contribution of MTrPs to 
the RCS has not been fully addressed (Gerwin et al 1997).
The presence of MTrP’s alters the function of muscles (Perez-Palomares et al 2007).  
Table 1.1 shows the recommended criteria for MTrP identification based on Simons et al 
(1999), to which could be added an additional characteristic of reduced muscle power in 
the involved muscle/s (Dommerholt et al 2006).  If the involved muscles are stabilising 
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Table 1.1:  Recommended Criteria for identification of MTrPs
Recommended Criteria for identification of MTrPs
Dommerholt & Huijbrechts 2010
Dommerholt et al 2006*
Essential Criteria Confirmatory observations
Taught palpable band (if palpable) Visual/tactile confirmation of local twitch response
Exquisite spot tenderness in a nodule of a 
taught band
Imaging of a Local Twitch Response 
(LTR) induced by needle penetration of a 
tender nodule
Patient pain recognition of current pain 
complaint by pressure on tender nodule
Pain or altered sensation in the 
distribution expected from a trigger point 
in the muscle on compression of the 
tender nodule
Painful limit to full stretch range of motion
Electromyographic demonstration of 
spontaneous electrical activity 
characteristic of the active loci in the 
tender nodule of a taught band
Muscle weakness as a result of muscle 
inhibition*
muscles, then the neutral zone control of the relevant joint is negatively affected, either 
into “give” or “restriction," either of which may cause pain and movement dysfunction 
(Comerford & Mottram 2001).  Lippitt & Matsen (1993) have argued for the importance of 
dynamic muscle contraction in the maintenance of stabilisation of the concavity 
compression forces around the glenohumeral joint. They point out that inherent structural 
instability of the glenohumeral joint means that ligamentous structures alone are incapable 
of preventing glenohumeral translation throughout the entire range of movement.  This is 
particularly the case in the mid-range of movement.  The implication is that the contractile 
elements around the joint are necessary for proper joint function, and that abnormal 
muscle function will result in abnormal arthrokinematics.  It is therefore reasonable to 
investigate the effect of direct treatment of MTrPs on RCS.
1.2.  THE PLACE OF DRY NEEDLING IN PHYSIOTHERAPY
One of the recommended techniques for treating MTrPs is dry needling (Dommerholt & 
Huijbregts 2010; Tough et al 2008).  Dry needling is the name given to the use of medical 
grade needles in the treatment of myofascial pain and dysfunction.  It is a therapeutically 
and theoretically distinct entity, not to be confused with the Traditional Chinese Medicine 
(TCM) technique of acupuncture (Travell and Simons 1999). It has been operationally 
defined by the Virginia Board of Physical Therapy’s Task force on Dry Needling as follows: 
“Dry Needling is a technique used to treat myofascial pain that uses a dry needle, without 
medication, that is inserted into a trigger point with the goal of releasing/inactivating the 
trigger points and relieving pain” (Virginia Board of Physical Therapy 2007: 2).  This 
modality may thus be a potential tool for the treatment of RCS.
1.3.  PROBLEM STATEMENT
There are various forms of dry needling described in the literature such as Superficial Dry 
Needling (SDN) (Baldry 2002; Edwards & Knowles 2003) and Deep Dry Needling (DDN) 
(Hong et al 1997a; Tsai et al 2010). There is debate as to the relative efficacies of each of 
these techniques (Ceccherelli et al 2001, Ceccherelli et al 2002).
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Rotator cuff syndrome
(See 2.3)
Dry needling
(See 2.6)
A common condition affecting the shoulder.  
Symptoms include a combination of pain, loss of 
range of movement and decreased strength of the 
affected shoulder (Ferguson 2005)
“Dry Needling is a technique used to treat myofascial 
pain that uses a dry needle, without medication, that 
is inserted into a trigger point with the goal of 
releasing/inactivating the trigger points and relieving 
pain” (Virginia Board of Physical Therapy 2007: 2)
Table 1.2:  Definitions of RCS and DN
1.4. RESEARCH QUESTION
What is the relative efficacy of each of three different forms of dry needing plus a 
conventional physiotherapy regime versus that physiotherapy regime alone when used in 
the treatment of RCS?
1.5. RESEARCH AIM
This pilot study aimed to assess the relative efficacy of three forms of dry needling in RCS 
and compare these to a conventional physiotherapy intervention.
1.6. RESEARCH OBJECTIVES
1.6.1.Compare the changes in Constant-Murley scale scores between 
patients treated with the four interventions on a pre-trial / follow up visit basis 
for each group.
1.6.2.  Compare the changes in Constant-Murley scale scores, ROM, Power 
in patients on a pre-intervention / post-intervention (intra-treatment) basis at 
each treatment for each group. 
1.6.3.  Compare the changes in Constant-Murley scale scores in patients on 
a between intervention (inter-treatment) basis at each treatment for each 
group 
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1.7. SIGNIFICANCE OF THE STUDY
The study aimed to gain clarity as to the clinical efficacy of dry needling when used in 
combination with a common physiotherapeutic intervention in treating RCS.   Specifically, 
the study intended to show there was a difference in both the effects, and the time needed 
to show the effects of the dry needling (DN) techniques.   Implementation of this approach 
may have benefits to patients in terms of a more nuanced approach to the scheduling of 
DN treatments.   
1.8. Conclusion
The general background to the study has been given, and the similarity of RCS symptoms 
to those of MTrPs shown.  Three research objectives that follow from the specific research 
question generated from this similarity have been identified.  In the chapters that follow, 
these objectives will be met by:
 Developing the general background given into greater specifics of the 
components used in the study by means of a literature review (Chapter 2)
 Defining the methodology used to investigate the research objectives (Chapter 3)
 Reporting on the findings of the investigations into the three research objectives 
(Chapter 4)
 Discussing the results of the study and making recommendations for further 
investigation (Chapter 5)
A comprehensive collection of Appendices relevant to the study is given at the end of this 
document including the Ethical Clearance certificate.
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2.  LITERATURE REVIEW
2.1. INTRODUCTION AND METHOD
This review of the published literature details the key problems which informed the design 
and thrust of this research report.  Key terms used in the study are defined herein, and the 
chapter includes a brief historical review of the definition of dry needling and its place 
within musculoskeletal therapy.  The key concept of the myofascial trigger point and its 
relevance to rotator cuff pathology is reviewed.  It reviews the suitability of the Constant-
Murley scale as the key outcome measure for the study.
Computerised searches of the Cochrane, PubMed and PEDro were conducted using the 
search terms “dry needling”, “rotator cuff syndome”,”trigger points” and “shoulder pain”.  
Additional papers were sourced using the reference lists of the results of the above 
searches, and from those listed in academic texts related to the issues under discussion. 
2.2. THE PROBLEM OF SHOULDER PAIN IN PHYSIOTHERAPY
In a systematic review of physiotherapeutic interventions such as myofascial release, 
exercise and electrotherapy for “shoulder pain”, Green et al (2003) identified only 26 trials 
of sufficient data quality for a meta-analysis, and concluded that there was little evidence 
to guide existing physiotherapeutic treatment of conditions causing shoulder pain, stiffness 
or disability.  Poor definition of the problem and methodological weaknesses in the studies 
hampered the conclusions.  The diagnosis of rotator cuff syndrome was included in the 
study, but MTrPs were not specifically addressed.   
2.3.  DEFINING ROTATOR CUFF SYNDROME
Poor definition of the diagnosis hampered Green et al (2003) in their analysis.  The 
diagnosis of RCS must be defined here to avoid a similar difficulty.  However, a close 
definition of the term does not appear possible.  Lewis (2008) considers RCS and the 
related subacromial bursa to be the most prevalent causes of shoulder pain in humans.  
The diagnosis is usually made on the basis of one or more described eponymous tests 
(Neer’s, O’Brien’s etc) and/or the findings of diagnostic imaging studies (MRI, Sonar).  
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Lewis (2008), citing Lewis (2007) and the Hegedus et al (2008) review has cogently 
argued against the use of such tests based on three factors.
•  The impossibility of clinically isolating individual components of the cuff.  The described 
tests are not specific enough to be valid
•  The anatomical location and features of the subacromial bursa.  The bursa appears to 
have a large and underreported role in shoulder pain
•  The lack of correlation between imaging findings and clinical findings.  
In the absence of a single valid test, Lewis (2008) has proposed a new diagnostic 
procedure based on symptom provocation and finding a mechanical alteration which 
alleviates the provoked symptom. This Shoulder Symptom Modification Procedure (SSMP) 
is a series of four sequential mechanical techniques which are applied by the therapist to 
the patient while the patient performs a pain provoking movement.  These are employed 
sequentially on a needs basis - if the patient does not obtain full relief on the first battery of 
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Figure 2.1: Lewis’ SSMP approach to RCS
Lewis 2008 Br J Sports Med 43:250
which position has the most beneficial effect on symptoms
(fig 2).
Muscle contraction procedures involve resisted movements
that modify muscle activity at the shoulder, altering the pattern
of shoulder muscle contractions th t may influence symptoms.
Examples include repeating the aggravating activity during a
sustained contraction of the shoulder external rotators, humeral
head depressors and/or adductors. In this instance, lightweight
resistance with rubber tubing is used to create the muscle
contraction during the movement to determine its effect on
symptoms (fig 3). Procedures that may influence the humeral
head position via muscle contraction may be relevant in
managing symptoms. Superior translation of the humeral head
on the glenoid fossa is observed in patients with subacromial
impingement syndrome nd ro ator cuff disease,38 39 and
procedures that activate humeral head depressors may counter
this translation.40 If a particular movement results in the
complete cessation of symptoms then the testing process is
over. If there is only a partial reduction in symptoms the
amount is noted and other compo ents of the SSMP are tested
to determine whether a better response is achieved from
another technique or whether a combination of techniques
results in a greater reduction of symptoms.
Changing scapular position
A series of manual techniques to slightly modify the scapular
position are applied to see whether symptoms change during
the aggravating movement. The changes made to the scapular
position should be relatively small. If manual techniques are not
possible, the application of tape to facilitate a change in scapular
position may be considered.35 The changes may be in one plane
of movement or in combinations of planes of movement.
Cervical and thoracic region procedures
Structures within the cervical and thoracic region may refer
pain to the shoulder. A variety of procedures, often described as
muscle, soft tissue, osseous and joint-based techniques, should
be applied to determine their effect on the patient’s aggravating
movement. The effect of changing the thoracic kyphosis is also
investigated. The patient’s thoracic kyphosis is reduced either
through ge tle manual reduction or via taping (fig 4). Once this
is achieved the aggravating activity is retested to determine the
response. Taping the thoracic region and shoulder does not
appear to have a placebo effect on pain and range of shoulder
movement.35
Although the order of the techniques used in the SSMP is
interchangeable, two important aspects need to be considered.
First, the magnitude of the change in pain experienced by the
patient as a result of one or a combination of techniques during
the SSMP process should ideally be a minimum of 30% change
from the baseline pain using a numerical pain rating scale
(NPRS). Although any single SSMP or combination of SSMPs
that both the patient and clinician agree on can be used, a 30%
change represents a substantial and meaningful change for
patients.41 42 Second, there should be consistency of response to
the SSMPs that have been selected. There should be a similar
Figure 1 The shoulder symptom modification procedure.
Original article
Br J Sports Med 2009;43:259–264. doi:10.1136/bjsm.2008.052183 261
 group.bmj.com on February 28, 2012 - Published by bjsm.bmj.comDownloaded from 
interventions, the therapist moves on to the next battery until full relief is obtained (see 
Figure 2.1).
This approach has the benefit of solid clinical reasoning, but the method does not yet have 
widespread adoption and required further empirical research and refinement before it can 
be clinically adopted as an alternative to the currently used, but flawed, common tests.
For clarity, and the above discussion notwithstanding, in this research report, the term 
RCS will be taken to mean a positive result on the tests given on in the Inclusion Criteria 
(Table 3.1) i.e. positive Neer’s or Hawkins-Kennedy impingement signs (Magee 1997:219).
Myofascial trigger points (MTrPʼs) have characteristic symptoms which mimic those found 
in rotator cuff pathology (see Table 1.2), but the contribution of MTrPʼs to the pathology 
has not been fully addressed (Gerwin et al 1997). 
Table 2.1: Comparison of the similarity in symptoms of RCS and MTrPs in muscles of the 
rotator cuff
Comparison of the similarity in symptoms of RCS and MTrPs in muscles of 
the rotator cuff
RCS MTrPs
Local pain over shoulder joint Active MTrPs cause local joint pain
Referred pain into the arm Rotator cuff muscle MTrPs refer pain in a predictable pattern in to the arm
Reduced range of glenohumeral 
movement
Knotted myofibrils cause functional 
shortening of muscle and consequent 
reduction of range of movement in the 
glenohumeral joint
Reduced power in arm movements
Knotted myofibrils reduce recruitment of 
muscle fibres with consequent loss of power 
in the rotator cuff muscles
Reduction in ADL performed by the arm Pain and loss of range cause muscle guarding and kinesiophobia
Pain is aggravated by sleeping on 
shoulder
Lowered pressure point threshold of MTrPs 
results in pain when the muscles are 
compressed between the body and the 
mattress
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2.1.THE EFFECT OF MTRPS ON MUSCLES 
The presence of MTrP’s alters the function of muscles (see Table 1.1) The therapeutic 
effects of dry needling are ascribed to the “deactivation” of MTrP’s (Travell & Simons 1992; 
Chen et al 2001; Hsieh et al 2007).  The mechanisms will be elucidated later.  
Indeed, the 1983 publication of the first volume of the Manual of Myofascial pain and 
Dysfunction (Travell and Simons 1999) represented a radical departure in medical circles 
precisely because it challenged the dominant orthopaedic surgical paradigm which holds 
that – with regard to musculoskeletal injuries - only structural problems can cause pain.  
This seminal publication, referenced in this report in its second edition (1993), has been 
largely responsible for establishing the scientific basis for the consideration of myofascial 
sources for pain as evidenced by the increasing numbers of studies which reference the 
work (Bron et al 2010, Hidalgo-Lozano et al 2011).
This study focussed on the myofascial aspects of RCS, specifically the phenomenon of the 
MTrP.  The significance of the symptomatic correlation between RCS and MTrPs is that it 
suggests that at least a part of the presenting signs and symptoms of rotator cuff 
syndrome could be explained by the presence of MTrP’s.  The relative contributions of 
neural dynamics, motor control, postural alignment and other known contributory factors 
falls outside of the scope of the study.
It is not possible to conclusively state the extent to which this prima facie case may be 
true, for as Bialowsky et al (2009) have pointed out, it is not possible to isolate the specific 
effects of manual therapies. The interaction of the neuromusculoskeletal components is 
often too close to be clinically separated.
MTrPs have previously been implicated in myofascial dysfunction.  In a single case study, 
Cummings (2003) reported relief of pain and neurological symptoms relating to a MTrP in 
the Pectoralis Major muscle (caused by an intercostal drain) using dry needling.
Ingber (2000) showed that a combination of dry needling and therapeutic stretching was 
clinically effective in treating shoulder impingement problems in three case reports of 
refractory pain in racquetball sufferers; the improvements were in joint range, power and 
pain sensitivity.  A similar approach to treatment of the Psoas major muscle also yielded 
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encouraging results in a series of six patient with “failed lower back syndrome” regarding 
lumbar spine and hip range of movement (Ingber 1989).  Huguenin et al (2004) assessed 
the effect of dry needling MTrPs in the gluteal region on the straight leg raise test but 
found no significant correlation.  Chen et al (1998) have shown in a two patient case report 
that relief from chronic chest wall pain caused by herpes zoster infection of intercostal 
nerves may be alleviated by treatment of MTrPs in the intercostal muscles.  Wheeler et al 
(1998) assessed the effectiveness of treating chronic refractory neck pain using Botulinum 
toxin infiltrations of MTrPs, but found no significant differences between the injection of 
normal saline and Botulinum toxin, although both groups did improve significantly. 
Botulinum toxin was selected as it is a potent acetylcholine antagonist, active at the 
neuromuscular junction.  MTrPs are a pathological phenomenon specific to the 
neuromuscular junction, and are thought to involve the abnormal release of acetylcholine 
at this junction (see 2.5).
There are electromyographic indications that the muscle dysfunction seen in myofascial 
pain syndromes may also have a neural component. Hubbard and Berkoff (1993) showed 
abnormal EMG activity in muscles at rest when the electrical potential difference was 
measured between MTrPs and the taught band compared to uninvolved parts of the 
muscle, signalling abnormal autonomic stimulation of the muscle spindles, increasing 
resting tone in the muscle.  Chu (1997) noted that EMG needling of the cervical muscles in 
patients arm and neck pain was positively correlated with clinical reduction in pain when 
the sites needled were MTrPs but not when the sites were randomly selected. Similarly, 
Fricton et al (1985) have shown motor unit activity to MTrPs to be significantly higher to 
that of normal muscle and this is related to “progressive abnormal muscle change from a 
functional neuro-dystrophic stage to an organic musculo-dystrophic stage” (ibid 1985: 
316).  Bialowsky et al’s (2009) clinical caveat regarding the interaction of muscle and 
nerve alluded to above find resonance in the MTrP. 
2.2.  THE MYOFASCIAL TRIGGER POINT
A myofascial trigger point (MTrP) is a hyperirritable locus in a skeletal muscle associated 
with hypersensitive palpable nodules within a taught intramuscular band (Fricton et al 
1985; Travell and Simons 1999).  Previously, the MTrP was also not consistently shown by 
electron or light microscopy (Hubbard and Berkhoff 1993).  However, the hypersensitive 
nodule is now biochemically (Travell and Simons 1999), histologically (Shah et al 2004) 
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and electromyographically (Hubbard and Berkhoff 1993; Simons et al 2002) 
distinguishable, and is readily palpable (Chu 2000).  It is distinct from a tender point, but 
the two may be coincident (Jimbo et al 2008).
The key clinical features of MTrP’s are patient recognised pain, loss of range of motion in 
the associated joint, decreased muscle power without atrophy, a local twitch response 
(LTR), autonomic symptoms and reproduction of the patient’s familiar symptoms 
(functional deficits) (Gerwin et al 1997; Hong & Simons 1998)(see Table 1.1).
 MTrPs were previously thought to be secondary to primary joint disease (Reynolds 1981).  
However, in the current conception, the cause of these phenomena is ascribed to the 
affected area being in a state of energy crisis due to a lack of oxygen supply according to 
the “Integrated Hypothesis” (Hong & Simons 1998).  This central idea of an oxygenation 
supply problem is hinted at by Jimbo et al (2008) who have identified (in a small population 
sample of patients with tender points) that the time taken for a muscle to exhibit recovery 
from a hypoxic state is reduced by the application of a non-stimulated needle a day before. 
Gerwin et al (2004) concurred with this hypothesis and have proposed an expansion to it 
to account for new experimental data and established muscle pathophysiology.  They 
emphasised the importance of the balance between the release of, and the breakdown of, 
acetylcholine (ACh) in the injured muscle. ACh is the major neurotransmitter involved in 
motor end plate function (Gerwin et al 2004, Niddam 2009). McPartland and Simons 
(2010) state that the MTrP phenomenon centres upon dysregulated motor end plates, and 
that this phenomenon is sustained by a neural loop of sensory afferents and autonomic 
afferents.
The focus on understanding the pathological features of the MTrP has revolutionised 
treatment approaches to myofascial pain (Dommerholt & Huijbreghts 2010).  The 
apparently diverse approaches involving myofascial tissues, local and systemic 
biochemical factors and the neural components has found expression in the “Integrated 
Hypothesis” relating to the motor end plate (Travel & Simons 1999).  More recently, this 
model has been modified to account for the increasing amount of molecular and genetic 
evidence supporting the model (Dommerholt & Huijbreghts 2010).  The nidus of MTrP is 
chemically distinct, and is typical of a painful area.  There are also features of antidromal 
production of Substance P and CGRP, which point to centralised pain generation (Shah et 
al 2005).  It appears as if MTrPs may have pathological features in the presynaptic, 
intrasynaptic and postsynaptic parts of the motor end plate.  An in depth examination of 
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these features is beyond the scope of this pilot study, but it important to note that the core 
element is a relative hypoxia in the muscle tissue which primarily results in peripheral 
symptoms, and that it is reasonable to expect a local intervention which targets the 
hypoxia (i.e. one that improves local blood oxygen delivery) to show more clinical benefit 
than a non-humoral mechanism.  
This study was designed to assess the effect of treating the MTrPs on the typical 
symptoms of a RCS.  The specific modality of treatment chosen was DN.  By definition, 
DDN causes local intramuscular bleeding, whereas SDN does not.
2.3. DEFINING DRY NEEDLING
The term ”dry needling” is not a globally recognised term.  It is used in South Africa, Spain,  
Australia, and in selected states within the United States of America among other 
countries, but the terms “Medical acupuncture” and Western acupuncture” are used in the 
United kingdom.  The subgroup of the World Confederation for Physical Therapy (WCPT) 
dealing with needling therapy is International Acupuncture Association of Physical 
Therapists (IAAPT).  However In Australia - a founding member of the IAAPT, the member 
group dealing with needling therapy is called the “Acupuncture and dry needling 
group” (italics mine).  Confusion between dry needing and acupuncture has lead to lack of 
clarity regarding the indications for dry needling treatment.  However, a commonly 
accepted definition of dry needling would include the elements of:
• the use of a filamentous needle
• which is inserted into the skin and/or muscle
• particularly targeting the MTrP
• to treat musculoskeletal pain and dysfunction (See Dommerholt et al 2006;  Virginia 
Board of Physical Therapy 2007: 2)
Green et al (2005) published a systematic review of acupuncture interventions for shoulder 
pain in which they concluded that there is insufficient evidence to determine the efficacy of 
acupuncture for “shoulder problems”.  There was no specific focus on the MTrP in this 
study as would have been the case if the needling technique was of the dry needling 
variety.  However, an internet search of the PEDro, Medline, Cochrane and PubMed 
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databases did not reveal a randomised control trial which addresses the myofascial trigger 
point component of rotator cuff pathology with regard to dry needling specifically.
The most recent and comprehensive needling study identified in the Cochrane database 
was published in 2005 by Furlan et al (2005). This is a systematic review of acupuncture 
and dry needling therapies as used in treating “low back pain” pathologies.  The findings 
indicate that a difference exists between the modalities.  The authors concluded that dry 
needling, but not acupuncture, appears to show clinical benefits when used for treating low 
back pain.
A further discussion of the differences can be found in Dommerholt et al (2011).  The 
authors developed the abbreviation TrP-DN to indicate Trigger Point Dry Needling, and 
differentiate this from any suggestion of similarity to acupuncture.
  “From a physical therapy perspective, TrP-DN has no similarities with traditional 
acupuncture other than the tool” (ibid 2011:179).
Despite the continued use of dry needling in the clinical setting, there is no clarity on the 
best clinical practice regarding the technical use of dry needling. This study attempted to 
identify which of the two main forms of dry needling showed the greater therapeutic benefit 
by defining them clearly and then comparing each of them to both a control and a placebo 
group (see 1.3)
A major distinction between acupuncture and dry needling lies in the importance of the 
MTrP. The most recent and comprehensive needling meta analysis identified was 
published in 2001 by Cummings & White.  The objective of the Cummings and White 
review was to “establish whether there is evidence for or against the efficacy of needling 
as a treatment approach for myofascial trigger point pain” (italics mine), and included both 
acupuncture and dry needling randomised control trials which treated myofascial pain.  
They made four conclusions as follows:
1.  Direct needling of myofascial trigger points (MTrP’s) appears to be an effective 
treatment for the symptoms of myofascial pain.
2.  The nature of the effect is due either to the needle itself or to placebo, rather than 
the injected substance.
3.  There was no clinical trial evidence to either support or refute the hypothesis that 
needling has an effect beyond that of placebo.
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4.  Controlled trials are needed to investigate whether needling does indeed have an 
effect beyond that of placebo.
This review also highlighted the lack of consistency in interventions. Although the studies 
all claimed to be studying myofascial pain, only eight of the twenty-three included trials 
include strict minimum diagnostic criteria for myofascial trigger points as formulated by 
Gerwin (1997). Of these, only a single study reported on the phenomenon of a local twitch 
response, which is clinically considered an essential indicator of therapeutic success 
(Hong 1994b; Travell and Simons 1999; Chen et al 2001; Chu et al 2002; Irnich et al 2002; 
Shah et al 2004; Shah et al 2005).  The Ceccherelli et al (2001) study was not included in 
the review, but it too does not mention the local twitch response.  It is not therefore 
surprising that a consistent comparison with placebo could not be established, as the 
interventions themselves are only nominally comparable.  
This pilot study sought to elucidate this problem by defining the modalities used and then 
comparing them (see 1.3).
Hong et al (1997a) cogently and scientifically argued for a dry needling technique used in 
treating MTrP’s which seeks the elicitation of a LTR.  In this they are supported by Alencar 
(2008).  A LTR is a brisk transient contraction of a portion of any given muscle, and is 
distinct from a more general “jump sign” which is demonstrated when an entire limb or 
body segment is moved away from a noxious stimulus.  It is a primarily a centrally 
mediated, spinal reflex phenomenon (Hong 1994a) and is a valuable objective sign that 
confirms the presence of a MTrP (Hong 1994c). The elicitation of a LTR has been 
described as “a necessary sign that must be obtained to ensure penetration of the 
myofascial trigger point” (Gerwin & Dommerholt 1995:8).  Dry needling the MTrP is an 
easier way of eliciting a LTR than can be achieved by digital palpation (Hong et al 1997a).  
Chu (2000) has reported that the clinically similar TOIMS (Twitch Obtaining Intramuscular 
Stimulation) technique was significantly more clinically effective than standard treatments 
for MTrP’s.   In a study comparing the injection of different concentrations of local 
anaesthetic into myofascial trigger points, Alencar et al (2008) described the importance of 
eliciting this LTR even when infiltrating a muscle with either a local anaesthetic like 
Procaine (registered as Novocaine in South Africa) or a corticosteroid.  This method of dry 
needling (DDN) is beginning to gain currency as a standard technique, as demonstrated 
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by its use in recent publications (Gallego & del Moral 2007, Fernández-Carnero et al 2009, 
Tsai et al 2010, Ay et al 2010).  
DDN is the first form of DN included in this study.
The second form of dry needling to be included in this study is SDN, which involved the 
placing of a dry needle into the skin superficially to a MTrP.  This technique is detailed in 
the next section, which also explains the reasoning behind including both techniques in the 
study (see 1.3)
2.4. A DISCUSSION OF SUPERFICIAL VERSUS DEEP NEEDLING
Several attempts to evaluate the relative efficacy of the techniques of deep, or 
intramuscular dry needling, versus the more superficial, or intradermal technique have 
been made.  A discussion of some of these papers follows below.
One of the most influential clinicians in the field is Peter E.Baldry, Emeritus Consultant 
physician and is generally held as the authority on the superficial needling technique.  In 
his contribution to a debate held at the ICMART 10th World Conference in 2002, he laid out 
his position on the matter, and indicated that fully 90% of his patients were treated with the 
superficial technique alone (Baldry 2002).  A description of the technique he proposed in 
that paper serves as a basis for this discussion.
Baldry (2005) typically used a 0.3x30mm long needle, but only inserted the needle 
5-10mm.  In this he employed a technique similar to the acupuncture approach.  (It is the 
depth of the point of the needle rather than the length of the needle that defines the 
technique). The needle was inserted shallowly into the skin and left in place for a period of 
time (usually 30 seconds) in which the needle was stimulated such that both the “jump 
sign” and the “shout sign” are abolished.  These were defined as effects of the palpation of 
the exquisitely tender trigger points.  If these were not abolished, the needle was 
reinserted and left for a number of minutes, with the option of further stimulation.  Baldry 
emphasised the need for muscle stretches and the use of postural advice post needling.  
He also identified 5 main reasons for choosing the superficial technique over the deeper 
one when the primary complaint is of uncomplicated, nociceptive myofascial trigger point 
pain:
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1. Personal experience of effectiveness over many years of practice
2. Ease of performing the technique
3. Relatively painless compared to deep needling (barring the “prick”)
4. Minimal risk to nerves, blood vessels and other structures
5. Minimal bleeding and therefore low incidence of post-treatment soreness
Baldry (2005) identified the neural mechanism of operation posited by Bowsher (1988) as 
the mechanism of action used by superficial needles to treat the uncomplicated, 
nocioceptive myofascial trigger point pain.  In this theoretical mechanism, stimulation of A-
δ fibres on the dorsal horn cell (whereby an inhibitory endogenous enkephalinergic 
response is generated), caused both pre-and–post synaptic blocking of nocioceptive 
Group IV afferent transmissions at a central, or spinal cord level.  This is a neural, rather 
than a humoral mechanism, and was thought to have an effective analgesic effect in the 
acute phase, as well as in down-regulating the effect of central sensitisation in more 
chronic states.  The effect of the stimulation of A-δ fibres at a central level may have an 
effect at a peripheral level via the phenomenon of antidromic stimulation of both 
Substance P (SP) and Calcitonin-Gene-related-polypeptide (CGRP) (Shah & Gilliams 
2008).  
The effect of this central neural mechanism on peripheral neural sensitivity raises a 
methodological problem. Bialowsky et al (2009) have noted that current literature fails to 
acknowledge the combined effect of neurological and biomechanical effects of manual 
therapies.  They suggest that a mechanistic stimulus may give rise to a number of 
potential neurological effects, and that the clinical outcomes seen by manual therapists in 
treating musculoskeletal pain may best be described as the cumulative effect of neural and 
mechanical factors.  This cautionary observation is not limited to a discussion around dry 
needling alone, but to all physical therapy
Physiotherapists Edwards and Knowles have published an assessment of the effect of 
superficial needling on myofascial pain (Edwards & Knowles 2003).  In this pragmatic 
single-blind randomised control trial, the use of superficial needling combined with an 
active stretching programme was shown to be more effective than the use of an active 
stretching programme alone (with respect to both pain as measured on the Short Form 
McGill Pain Questionnaire (SFMPQ) and Pressure Pain Threshold (PPT) after 6 weeks of 
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treatment).  This was especially true of the reduction in pain scores (SFMPQ), and less so 
of pressure pain threshold (PPT).  (The authors identified a similar list of advantages of 
SDN, but did not cite the Baldry (2005) paper above.
The point to note from this study is the nature of the improvement in the patient’s pain – it 
is in the perception (SFMPQ score), rather than the objective reality (PPT), again reflecting 
the neural rather than humoral effect.  This self reported variable could be ascribed to the 
placebo effect.
Ceccherelli et al (2001) utilised a randomised control group to assess the relative efficacy 
of superficial acupuncture versus deep acupuncture in a group of patients 40-65 years of 
age with shoulder pain.  This study was unusually explicit in detailing the depths to which 
the needles were inserted in each group.  In the superficial group, the needles were 
0.3x15mm in size, and inserted to a depth of just 4mm into the skin.  In the deep group, 
the needles were 0.3x25mm in size and inserted to a depth of 25mm into a muscle.  All the 
insertion points chosen were classical acupuncture points rather than MTrPs, and were 
rotationally stimulated.  The outcome measure was the MGPQ, specifically the pain rating 
index and the number of words chosen.  Both parameters were shown to have a 
statistically significant improvement in both groups (p<0.05) for a “before and after” 
analysis, and this was maintained at a 3 month follow up.  However, the magnitude of the 
change was markedly different.  For the superficial group, an improvement of 38.49% was 
found, while the deep group showed an 86.38% reduction in pain.  The magnitude of 
change in the superficial group is again close to that which can be expected from a 
placebo effect (33%).  It is not clear if there was any attempt to address myofascial trigger 
points or elicit local twitch responses in this study, despite the title’s reference to 
“myofascial pain”.
Similarly, Ceccherelli et al (2002) previously attempted a comparison of deep and 
superficial acupuncture in a double-blind randomised control study group of lumbar 
myofascial pain.  Again, the MGPQ was used and the same two parameters chosen.  
Again, classical acupuncture points of insertion were chosen, but in this study, four “trigger 
points”, or the four most painful muscular tender points, were also needled.  The depth of 
insertion of the superficial group was 2mm into the skin of both the acupuncture points and 
superficially over the trigger point areas.  The deep group were similarly uniformly needled 
to 15mm, despite differences in subcutaneous tissue thickness.  The study design appears  
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to accommodate different tissue thicknesses as it discusses various lengths of needles, 
but the depth of insertion of the deep group (group B in the study) was uniform:
“In group B patients, the needle was inserted to a depth of approximately 1.5cm in the 
muscle or in the trigger points”(Ceccherelli et al 2002:151)
Again, all needles were rotationally stimulated.  It is not clear how the participants were 
blinded as to the group they were randomly assigned.  As noted above, one of the 
appealing aspects of superficial needling is that it is less painful than deep needling.  Such 
a condition cannot be said to be proper blinding, and as such this study is best regarded 
as a single-blind study.  The insufficient depth of insertion of the deep group should also 
be regarded as a significant methodological weakness, as is the statistical weakness of 
the study, which was powered at <80%.  
Notwithstanding these weaknesses, the study demonstrated no significant difference 
between the groups at the end of the 8 treatment cycle, but did show a better result for the 
deep group at a three-month follow up.  It is difficult to interpret these findings given the 
methodological weaknesses, but it is instructive to note the similarity of result from 
techniques which were both relatively superficial given the areas used.  Both techniques 
are essentially the same “superficial needling” in nature.  It appears as if the two groups 
could have been defined too narrowly, leading to the incorrect labeling of a technique as 
“deep” when a true deep technique should rather have been inserted more deeply, and 
actually penetrate the muscle.  Hong (1994b) has pointed out that it is imperative to 
penetrate the myofascial trigger point for deep needling to occur (and to elicit a local twitch 
response).  In Ceccherelli’s (2001) study of the previous year, the deep needles were 
inserted to a depth of 25mm (contra the 2002 study where 15mm was used) into a body 
region commonly far less prone to subcutaneous variation than the lumbar spine and 
buttock areas.  This inconsistent methodology reflects the common inattention to definition 
and standardisation that has plagued the field (see introduction).
In one of the better described studies, Huguenin et al (2005) similarly used a 25mm long 
needle to investigate the effect of dry needling on gluteal trigger points.  They pointed out 
that local twitch responses were obtained, and that the myofascial trigger points were 
needled until the local twitch responses were no longer observed.  This would seem 
contradictory given the above discussion where the needle length of 25mm was held as 
insufficiently long to adequately reach the deeper lying gluteal muscles.  The difficulty is 
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somewhat resolved when it is noted that the Huguenin study specifically recruited male 
athletes as participants, whereas Ceccherelli (2002) used a mixed sample taken from 
among the low back patients at a Pain Therapy unit.  Although Ceccherelli excluded 
patients for “obesity that does not allow the muscular insertion and stimulation of 
needles” (Ceccherelli 2002:150), it is possible that the average thickness of gluteal 
adipose tissue in trained athletes is significantly different to that of the average chronic 
pain patient. Certainly, the typical adipose deposition pattern between males (android 
pattern) and females (gynoid pattern) is phenotypically different, and these two factors can 
be considered confounding variables which make direct comparison difficult.
In the Huguenin (2005) study above, an attempt was made to assess the effect of the dry 
needling release of trigger points in the gluteal region by assessing the change in range of 
a straight leg raise and the change of range of hip internal rotation.  A Visual Analogue 
Scale was also used to rate the pain on running.  A single-intervention design (see 2.7), 
with measures taken immediately-before, immediately-after, 24-hours, and finally 72-hours 
after was employed.  No significant changes in VAS scores after running were observed, 
but resting variables were significantly improved immediately after intervention; they were 
however stable thereafter.  No significant differences between placebo and “real” needling 
in terms of range of motion for either the straight leg raise or for hip internal rotation were 
observed.  This lead the investigators to declare that these outcomes were of no value as 
reassessment measure after the treatment of gluteal trigger points.  The investigators 
noted that the findings of subjective improvement but objectively negative results (no 
better than placebo) is reflected in 2 other dry needling studies, neither of which is 
reflected in the systematic review by Cummings (Cummings 2001).  Karakurum et al 
(2001) Used a sample of 30 people to compare the effects of an intramuscular needling 
technique with a placebo technique in the treatment of tension-type headaches.  The 
intramuscular technique used was not of a twitch-obtaining type; the needles were left in 
situ for 30 minutes.  The “placebo” technique used was essentially superficial needling as 
the needles were inserted only subcutaneously.  This is not a placebo, but another form of 
needling (superficial needling).  This study thus compared a (sub-optimal) “deep” dry 
needling technique with superficial needling.  Indeed, both groups showed significant 
improvement (p<0.05) improvement in headache pain scores, with similarly matched 
scores for change in range of movement), beyond what would be expected from a mere 
placebo (+/-30%).  There was also a significant improvement in tenderness scores in the 
treatment group (p<0.001), and the difference in this score between groups was also 
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significant (p<0.001).  The conclusion drawn by Huguenin et al (2005) concerning the 
results of dry needling being no better than placebo cannot be supported from this study 
because of methodological difficulties.
As indicated above, there are two distinct effects occurring with any dry needle 
intervention, these being the effect of penetrating the skin (which both superficial and deep 
needles do) and the penetration of the myofascial trigger point, which is classically 
reserved for deep needles.  Superficial needles generate a neurally mediated effect; deep 
needles generate this as well as a humorally mediated effect (bleeding and the 
consequences of activating an inflammatory response), which will be elucidated below.  
Huguenin et al (2005) made mention of the humoral effects (citing Travell & Simons 1998 
but herein referenced as 1999), describing this as an “early theory” but did not distinguish 
between the deep and superficial effects.  The authors - while stating that the mechanism 
of pain relief associated with trigger point relief was unknown - ascribed the effects of the 
needle not to local muscle factors but to a centrally mediated analgesic effect, and in their 
discussion favoured neural processing explanations for the subjective relief rather than 
actual physical changes in the gluteal muscles (Huguenin et al 2005).  Several other 
papers dealing with the reduction in symptoms of myofascial trigger points have identified 
a spinal cord mechanism alone for this phenomenon (Audette et al 2004, Hsieh et al 
2007). However, these papers did not consider the paper by Shah et al (2005) which 
provides powerful evidence in favour of the local biochemical factor model as discussed 
below. 
There may be different mechanisms in play for each of these types of dry needling.  
However, the studies cited above seemed to indicate that a greater therapeutic effect 
could be expected from the DDN group as opposed the either of needing groups (SDN 
and PDN) or the control group when the MTrP is targeted with an LTR obtaining technique. 
It was not known how long it would take for the effects to manifest, but it was thought that 
the neural mechanism (SDN) would have an immediate effect, and the humoral 
mechanism (DDN) would demonstrate a delayed response.
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2.5. THE PHYSIOLOGICAL EFFECTS OF DRY NEEDLING
Alencar et al (2008:2) citing Han & Harrison (1997) identified five possible mechanisms for 
the success of trigger point injection therapy.  These apply principally to the injections of 
substances that can be injected (“wet needling”), and are as follows:
1. Mechanical disruption of muscle fibres and nerve endings
2. Mechanical disruption of muscle fibres, causing increased extracellular potassium, 
which leads to depolarisation of nerve fibres
3. Interruption of the positive feedback mechanism that perpetuates pain
4. Local dilution of nocioceptive substances by the infiltrated local anaesthetic or 
saline that is infiltrated
5. Vasodilatory effect of local anaesthetics, increasing the removal of metabolites
Alencar et al (2008) conducted a study comparing two such wet needling techniques 
(Group 2= lidocaine 0.25% without vasoconstrictor, Group 3= lidocaine 0.25% without 
vasoconstrictor, but with added Decadron 4mg/ml) with each other, and used a dry 
needling technique (the same needles, but no injectable substance in the syringe) in the 
control group (Group 1).  The major finding of this study concurs with findings of Hong 
(1994b) in that it was of little consequence which substance was injected as all groups 
improved significantly (p<0.05) with respect to pain intensity, frequency and duration, use 
of rescue medication, time and duration of relief.  The only parameter which showed a 
significant difference was that of post-needling soreness, which was less in group 3.  The 
same gauge needle was used in all groups.  This major finding was repeated in a study 
comparing the effects of Botulinum toxin A and physiological saline (Ojala et al 2006) and 
again in comparing Botulinum Toxin A with bipuvicaine (Graboski et al 2005).  These 
findings also correlate with those of Ay et al (2010) who used a randomised control study 
to examine the relative effects of dry needling and wet needling with 2ml of 1% lidocaine 
on cervical range of movement, psychological depression and pain (Ay et al 2009). In this 
study of 80 patients (but with limited statistical powering), the effects for both groups was 
found to be significant and matched at both 4 weeks and 12 weeks.  
Significantly, the groups in Ay et al (2009) did not show a difference in post-needling 
soreness, and this was ascribed to the use of the thinner, solid needles typically employed 
in the dry needling approach. Clearly the common element is that of the needle itself, or 
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“dry needling”, and the common effects of the various interventions can be ascribed to the 
mechanistic effects of the needle rather than the chemical effects of injected substances.  
This implies that, of the options given by Alencar et al (2008) citing Han & Harrison (1997) 
above, the better candidates for explaining the effect of dry needling were the first three 
possible mechanisms.1 The first two effects did not occur in the superficial DN (SDN) 
group in this study, while all three occurred in the deep DN (DDN) group.  This again 
seemed to favour the DDN group as the group which would show the greatest clinical 
effects2.
2.6.THE TIMING OF THE TREATMENT EFFECT
Srbely et al (2010) identified very short term reductions in pressure point sensitivity (<10 
minutes) after single episodes of intramuscular needling of MTrP-like entities which they 
refer to as “secondary loci of hyperalgesia”.  They hypothesised that a greater effect would 
be seen if mutiple loci were needled at repeated interventions3.  Srbely et al (2010) 
strongly advocated a neurogenic model, and did not address local biomechanical issues.  
This use of acupuncture-like needling was similar to Osborne and Gatt (2010) in 
interpreting the immediate change seen in acupuncture-type DN.  Osborne and Gatt 
(2010) published a case report in which acupuncture-like needling of MTrPs was used in 
the treatment of the shoulders of elite volleyball players during competition. The needles 
were inserted and then twisted to achieve what is purported to be a local stretch effect.  
The needle was twisted until the typical referral pattern of the muscle was reported by the 
patient.  This represents the specific targetting of the cardinal signs of a MTrP, as did 
Srbely et al (2010).  In contrast, Osborne and Gatt (2010) favour a biochemical 
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1 Hameroff et al (1981) found evidence for preferring Bupivocaine and Etidocaine injections over saline 
ones, but did not employ either a twitch obtaining technique nor a control.  Similarly, Graboski et al 2005 
compared the infiltration of trigger points using Botulinum A and bipuvicaine without looking at twitches, 
and found no significant difference between the two.  A home exercise programme was however 
employed in this study.  In a recent study, Ay et al (2009) employed a twitch obtaining technique, an 
appropriate size needle and an exercise programme, and found no difference between lidocaine (2ml of 
1%) and dry needling.
2 Srbely et al (2010) proposed that the needling of a MTrP has a segmental inhibitory modulation effect which 
was predominantly neural in nature.  They used the novel term “secondary hyperalgesic locus” in referring to 
the MTrP, calling them discrete secondary peripheral manifestations of a primary neural pathology within the 
common neuromeric field 
3 In the Srbely et al (2010) study, the primary parameters measured was Pressure Point Threshold (PPT).  
There was a highly significant difference between the needled group (accurate deep needling of the MTrP) 
and the control group (deep needling into the same muscle, but not into the MTrP) in this study at three 
minutes post intervention (p=0.0002) and at five minutes (p=0.015), but the groups were not significantly 
different by ten minutes post intervention
explanation for the changes seen in their elite athletes, which included changes to ROM, 
power and pain rather than PPT.  These parameters were noted to be improved by 24-
hours after therapy, barring one subject who required a second treatment (on day 2) of 
TOIMS, accompanied by a greater level of pain than the less aggressive “insert and twist” 
method. This lead to a great improvement on all parameters4.  Further treatments in the 
same competition did not yield greater functional gains; two sessions appeared to be 
enough in that elite athlete setting.  
Huguenin et al (2005) discussed above used a single-intervention method to investigate 
the effect of needling on MTrP’s in the gluteal muscles, but did not find evidence that 
needling affected the range of hip flexion even after a 72-hour follow up.
2.7. THE CONSTANT-MURLEY SCALE
Numerous outcomes scales have been used to assess the efficacy of dry needling (Hong 
et al 1997b; Ceccherelli et al 1998; Ceccherelli et al 2002; DiLorenzo et al 2004).  Ingber 
studied the use of dry needling in the treatment of subscapularis MTrP’s in isolated cases 
(Ingber 2000). Hsieh et al (2007) used a single blind study design with contralateral 
controls to show the effects on range of motion and on satellite MTrP sensitivity.  Edwards 
and Knowles (2003) studied the effects of superficial needling and active stretching on 
myofascial pain (Edwards 2005).  Both major forms of dry needling (SDN and DDN) are 
purported to address the MTrP (Kostopoulos and Rizopoulos 2001; Baldry 2002).  
However, a search of the databases mentioned above did not reveal any human studies 
which compare the deep and superficial dry needling techniques using validated outcome 
measures more suited to assessing the full spectrum of symptoms related to myofascial 
trigger points (MTrP’s).  An example of such a scale is the widely used Constant-Murley 
(C-M) scale (Constant & Murley 1985).  
2.7.1.Validity and reliability of the C-M Scale
The C-M scale reduces the combined therapeutic effect on pain, range of movement, 
activities of daily living, and strength to a single score an a 100 point scale.  Ramzjou et al 
(2008) have shown that this scale has moderate correlation (0.56 to 0.75) with other 
scales measuring individual aspects of shoulder function, and that is appears to reflect a 
component of shoulder compromise which is not captured by an analysis of the individual 
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4 There were only 4 participants in this case report.  No statistical significance figures were available.
components (range of motion, power).  They concluded that the use of the C-M scale was 
supported by their study in terms of construct validity, but recognised the need for 
specifically described methodology to facilitate study comparisons.  
Roy et al (2012) conducted a systematic review of the psychometric validity and reliability 
of the C-M scale.  They found the C-M score correlated strongly (>0.7) with other shoulder 
specific outcome measures like the Western Ontario Rotator Cuff index and the Simple 
Shoulder Test.  They found acceptable benchmark reliability coefficient scores (r > 0.80), 
and that the responsiveness of the scale in detecting an effect was in excess of (r>0.80) 
across a range of shoulder pathologies.   They cautioned that lack of methodological 
standardisation limited the external validity of their findings.
This is confirmed by Blonna et al (2012) who demonstrated improved reliability scores for 
both inter- and intra- rater reliability when conditions were standardised for both 
experienced and inexperienced observers.  
The C-M scale was used by Kleinhenz et al (1999) in a study of the effect of acupuncture 
on rotator cuff problems using this measure but did not directly address the MTrP in their 
study). This was an appropriate outcome measure to use in examining the full spectrum of 
the effects of MTrPs on RCS.  The Kleinhenz et al (1999) study was thus used as a 
methodologic and statistical base for the current study.  However, in view of the 
methodological limitations of the C-M scale, slight variations from the less rigorous original 
technique were used (see 3.2). 
This pilot study proposes to compare the effects of twitch obtaining intra-muscular dry 
needling (DDN), non-twitch obtaining superficial needling (SDN) and placebo needling 
(PDN) on myofascial trigger points associated with rotator cuff syndromes using the 
Constant Murley (C-M) scale to holistically assess the change in shoulder function and 
disability (see 1.6).
2.8.  Conventional physiotherapy interventions
There is little evidence to support traditional physiotherapeutic interventions (see 2.2).  
Bron et al (2011) found that in the treatment of shoulder pain where MTrPs was a feature 
of the pathology, a combination of myofascial therapies including stretching, postural 
advice, cryotherapy and ischaemic compression was significantly more effective than no 
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treatment (wait-and-see) (p<0.05) when using the Disabilities of Arm, Shoulder and Hand 
(DASH) questionnaire.  At the end of the study, the reduction in the number of active 
MTrPs was positively correlated with DASH improvements seen.  This result of the 
effectiveness of hands on myofascial treatment of MTrPs in the shoulder is supported by 
Hains et al (2010) using the Shoulder Pain and Disability index.  In this single blind, 
randomised crossover-control study, 41 patients with chronic shoulder pain were treated 
using ischaemic compression therapy, and showed a significant SPADI improvement 
(p=0.003) for the initial study.  A similar result was obtained when the control group 
received the active intervention in the crossover phase (p=0.001).  These recent studies 
indicate that the use of ischemic compression therapy may be useful in the treating MTrPs 
when used in combination with therapeutic exercise.
2.9.  THE ROLE OF THE INFRASPINATUS MUSCLE
The rotator cuff is the name given to the grouping of the muscles controlling the rotation of 
the glenohumeral joint.  The cuff consists of the Subscapularis, Supraspinatus, 
Infraspinatus and Teres Minor muscles.  Of these, Infraspinatus pathology is a known co-
factor in shoulder problems (Oyama et al 2011). Bron et al 2007b found that the palpation 
of the Infraspinatus muscle showed the highest inter-rater reliability of all the shoulder 
muscles5 assessed (Pair-wise agreement of 69-80%). On the basis of their findings, Bron 
et al 2007b proposed that MTrP palpation may potentially be a useful tool in the diagnosis 
of myofascial pain in patients with non-traumatic mixed pathology shoulder pain.
In this pilot study (See 4.1.2), incidence of MTrPs in the Infraspinatus muscle alone was 
almost equal to the incidence of the other three muscles combined.   A full examination of 
the relative contributions of each of the four cuff muscles is outisde of the scope of this 
pilot study, but the particularly skewed incidence of Infraspinatus MTrPs bears 
investigation of this muscle. 
The anatomical functions of the Infraspinatus muscle are to isometrically help maintain the 
head of the humerus within the glenoid, concentrically to laterally rotate the humerus at the 
glenohumeral joint, and eccentrically to check-rein the glenohumeral joint as it moves into 
medial rotation (Moore & Dalley 2006; Oyama et al 2011).  Clinically, classic findings of 
patients with rotator cuff pathology include reduced lateral rotation power of the 
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5 The muscles assessed were the Biceps Brachii and the anterior deltoid
glenohumeral joint, reduced internal rotation of the glenohumeral joint, and an anteriorally 
translated humeral head within the glenoid.  Oyama et al (2001) studied the effect of 
eccentric overloading of the infraspinatus muscle with respect to cross sectional area and 
shoulder range of motion.  They found a significant correlation between eccentric overload 
of the infraspiantus and the development of reduced internal rotation range of the 
shoulder.  This was correlated with ultrasonically identified increased cross sectional area 
of the muscles, and ascribed the effects to a combination of muscle damage and oedema 
accumulation but no accouting was made for the presence of MTrPs.  MTrPs are activated 
by eccentric overload, particularly in the inner and outer ranges of movement and can 
subsequently alter the functional activation of muscles (Mense & Simons 2001).  Ge et al 
(2008) noted that MTrPs in patients with unilateral shoulder pain (not more specifically 
diagnosed) tended to occur multiply ie not as single MTrPs within the Infraspinatus 
muscle. 
SUMMARY OF CHAPTER 2
Rotator cuff syndrome symptoms may be caused in part by MTrPs.  Dry needling is a 
modality of therapy for MTrPs, but has two distinct forms.  It is not known which form of dry 
needling may be clinically more effective in RCS patients, but evidence seems to favour 
DDN over SDN or placebo.  The C-M scale is well suited to assessing the full spectrum of 
the effects of MTrPs in shoulder patients, and has been used previously in a needling 
study of patients with RCS, but without focussing on MTrPs specifically.  There does not 
appear to be consensus as to the appropriate time to measure outcomes post needling, or 
how many sessions of needling are required to show maximal clinical benefit. The 
infraspinatus muscle may play a key role in RCS.
The aim of this study was to assess the relative of dry needling in RCS when added to a 
common physiotherapy regime compared to a common regime alone.
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3.METHODOLOGY
3.1. INTRODUCTION
In Chapter 3, the methodology for a pilot study assessing the relative effects of DDN, SDN, 
PDN and a physiotherapy regime CON on RCS patients will be laid out.
3.2.DESIGN  
The study was designed to be a single-blinded, randomised control study, with a validated 
placebo intervention as well as two other needling interventions, and a non-needling 
group, (4 groups).  The invasive nature of the technique precludes the use of a double-
blind design.
3.3. POPULATION
Participants were drawn from the referrals from 2 local orthopaedic surgeons, drawing on 
a population of the geographic area of the Gauteng West Rand towns (Krugersdorp, 
Randfontein, Mohlakeng, Bekkersdal, Simunye, Westonaria, Glenharvie and Hillshaven).  
3.4. SAMPLE
Each of the referred patients was asked to either participate in the study or not.  Patients 
that agreed were screened according to inclusion and exclusion criteria (Table 3.1).  All 
participants included in the study had a primary positive diagnosis of RCS based on the 
Hawkins-Kennedy or Neer’s tests.  The sample size was 5 per group, giving a total sample 
size of 20 participants.  
Details of the statistical considerations is given in 3.11
3.5. ETHICS
Ethical clearance for the pilot study has been obtained through the University of the 
Witwatersrand (Appendix K).
The concerns over possible side effects and the anticipated patient discomfort were 
addressed in the patient information sheet (Appendix B).  The most important side effect 
concerns the chance of causing a pneumothorax.  The accurate palpation of the MTrP, 
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correct selection of needle length and appropriate patient positioning reduce the risk of 
such an event to a very safe level.
3.6. RESEARCH SETTING
The study was carried out in the private practice rooms of Luke & Barker Inc 
Physiotherapy, located in the Medical Centre of Life Robinson Hospital, Randfontein, 
South Africa.
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3.7. PROCEDURE
All prospective candidates were greeted by the researcher and given the explanatory 
document (Appendix B) to read and asked to sign consent (Appendix C) to participate in 
this study based on this information.  Those signing consent were regarded as 
participants, and were randomly allocated to one of the treatment groups by means of a 
random number allocator administered by research assistants 1or 26.  Both assistants had 
been trained by the researcher in DN and MTrPs prior to the study, and received additional 
specific training on the procedures used in this study.  The randomly allocated number 
(RAN) was recorded on the patient’s demographic information sheet (Appendix A) and on 
all subsequent documentation.  No other link between identifying information and clinical 
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6 Both assistants had been trained in the appropriate techniques by the principal investigator
Table 3.1:  Inclusion and Exclusion criteria
Inclusion and Exclusion criteria
Inclusion criteria Exclusion Criteria
Limitation of shoulder range
Currently being treated for shoulder 
problems by a physiotherapist, 
chiropractor or biokinetician
Between 18-55 years of age Positive test for shoulder instability (Magee 1997:219)
Pain in the shoulder region for more than 1 
week Any previous needle therapy
Presence of discrete MTrPs which 
reproduce the patientʼs familiar pain Haemophilia
Positive Neerʼs or Hawkins-Kennedy 
impingement signs (Magee 1997:219) Known C5-C6 pathology
Previous shoulder surgery
Pregnancy
Needle phobia
Sportspeople currently competing at elite 
level
Lack of signed informed consent
data was made possible.  The initial assessment was the only document with uncodified 
identifying information on it and was physically stored separately from the trial data.
The initial assessment and Pre-Treatment assessment were conducted by the researcher 
in room 1, and recorded on the Shoulder Assessment Tool (Appendix F) (visit 1), or Pre-
Treatment assessment form (Appendix D) (visits 2-5) as appropriate.  The participant then 
proceeded to room 2 where the appropriate intervention was carried out by research 
assistant 1 or 2.  After treatment, the participant returned to room 1 for a Post-Treatment 
assessment which was recorded on Data collection sheet 2 (Appendix E).   Interventions 
were carried out every three days for four sessions in Randfontein.  A follow up fifth 
session (assessment only) was conducted in room 1 and recorded on Data Collection 
sheet 2 (Appendix E).  Patients were invited to this follow up assessment (session 5) one 
month after the fourth session7 (See figure 3.4). 
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7 The interval between sessions was based on the Kleinhenz, et al. (1999) study.  Only half of the number of 
sessions performed in that study were performed in this one for logistical and financial reasons.  However, a 
physical follow up was conducted after one month rather than a postal follow up as in the Kleinhenz study.
3.8. TREATMENT PROCEDURES
The treatment regimes are summarised in table 3.3.  All participants had the 
Supraspinatus, Infraspinatus, Teres minor and Subscapularis muscles gently palpated 
(less than 4kg.cm², determined as just enough pressure to cause slight blanching of the 
researcher/therapist’s finger) to locate active trigger points which were then physically 
marked on the both the skin and the assessment sheet by the researcher (Wolf et al 
1900).  The use of precise pressure measurement instruments (dolorimeters) in the 
palpation phase does not appear to carry any clinically significant advantage over simple 
digital palpation as long as the patient’s familiar pain is elicited (Lavelle et al 2007). The 
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Fig 3.3:  Placebo needle 
showing the shaft 
telescoping into the handle.  
All the needles shown are 
the same “length”
Fig 3.2  Tip of needles:  Placebo needle (left).  
Normal needle (right)
Table 3.2:  Needle lengths & Participant positioning
Muscle Deep Needle Superficial needle Needling position
Supraspinatus 0.35x75mm 0.22x13mm
Contralateral side 
lying, affected 
shoulder in neutral
Infraspinatus 0.3x30mm 0.22x13mm
Contralateral side 
lying, affected 
shoulder in neutral
Teres Minor 0.3x30mm 0.22x13mm
Contralateral side 
lying, affected 
shoulder in neutral
Subscapularis 0.35x75mm 0.22x13mm
Supine, with affected 
arm abducted as far 
as possible
participants were then taken to the treatment room where they were treated by the 
research assistant using the randomly allocated group protocols as detailed in Table 3.3. 
Table 3.2  Needle lengths and patient positioning
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Figure 3.4:  FLOW DIAGRAM OF STUDY PROCESS ! !
PATIENT PRESENTS FOR 
TREATMENT 
EVALUATION  
•  INCLUSION OR 
EXCLUSION?!!
FORMAL 
ASSESSMENT: 
APPENDICES A, C & F 
PRE TREATMENT 
C-M (APPENDIX D) 
TREATMENT  
(ASSISTANT) 
POST TREATMENT 
C-M SCALE 
(APPENDIX E)!
INTRA-TREATMENT 
CHANGE: 
 C-M DIFFERENCE BETWEEN 
APP D AND APP E OF SAME 
SESSION   
GAP BETWEEN 
TREATMENTS 
SESSION 5;  FOLLOW UP 
ASSESSMENT 1 MONTH AFTER 
TREATMENT #4 
SESSIO
N 
4 REPEATS  
3-4 DAYS APART:  
INTER TREATMENT 
CHANGE: 
C-M DIFFERENCE BETWEEN 
APP D OF NEW SESSION AND 
APP E OF PREVIOUS  
Figure 3.4:  Flow diagram showing at which stage the Inter- and Intra- treatment changes 
were measured
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Table 3.3:  Treatments given to intervention groups
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Table 3.3 :
 Treatments given to the intervention groups
CON DDN SDN PDN
Control group Deep dry needling Superficial dry needling
Placebo dry 
needling
 Hot pack (60C)
applied for 5 
minutes prior to 
treatment
 Digital ischemic 
pressure with 
pressure varied 
according to 
patientʼs pain 
tolerance, 
applied to 
MTrPs identified 
by palpation by 
researcher.        
(Manheim 2001)
 Passive 
stretches of 
internal and 
external 
rotators, 
shoulder flexors 
and extensors 
(Appendix G).
 CON plus the use of 
verum needles of 
appropriate length (see 
table 3.2) which were 
repeatedly inserted into 
the palpated MTrPs 
using a partial 
withdrawel and re-
insertion technique, 
causing maximal LTR 
elicitation in 30 seconds.  
 The therapists 
respected the patientʼs 
feedback using the 
question “how are you 
doing?”, and ceasing to 
move the needle if the 
needle grasp occurred or 
if the patient felt 
unusually uncomfortable.
 CON plus the use 
of verum 
0.25x13mm 
needles inserted 
intradermally 
superficial to the 
palpated trigger 
points.
 The needles were 
manually twirled to 
elicit maximal pin 
prick sensation in 
30 seconds.
 CON plus use of 
validated non-
insertional placebo 
needle 
(Streitberger and 
Kleinhenz 1998) 
over areas of the 
RC muscles where 
MTrPs were 
palpated.  
 Technique of 
repeated insertion 
was mimicked for 
30 seconds.
Note:  Placebo 
needle has a 
blunted tip and 
telescopes into the 
handle rather than 
being inserted into 
skin (see figs. 3.1 
and 3.2).
3.9. OUTCOME MEASURES
All measurements were conducted under standardised conditions in room 1.  
The Constant-Murley scale was used as an outcome measure, mimicking that of the 
Kleinhenz study (Constant & Murley 1985; Kleinhenz et al 1999). This scale was 
developed as an easy to use measure of shoulder function with broad application across 
shoulder pathologies.  It is a weighted scaling of the relative contributions of pain, effect on 
activities of daily living (ADL), effect on range of movement (ROM), and effect on strength.  
It gives a composite score out 100 possible points.  The pain and ADL parameters were 
assessed subjectively by the patient prior to the objective testing of ROM and strength (see 
Appendix D and E).
A physical follow up assessment using the C-M scale was conducted at one month after 
the fourth session.  This represents a difference to the Kleinhenz et al(1999) study in 
which follow up was conducted by means of a postal questionnaire four months after the 
final session.
Strength measurements were taken as isometric mid range maximum exertions using a 
hand held dynamometer (Nicholas Manual Muscle tester (Lafayette Instruments 3700 
Sagamore Parkaway North, Lafayette Indiana, USA)) at either 90 degrees of 
glenohumeral abduction or the maximum glenohumeral abduction the patient can achieve 
if this is less than 90 degrees as originally described (Sklaar 2000).  However, the use of a 
Nicholas Manual Muscle tester represented a departure from the original methodology in 
which a pound-denominated spring balance was used.  This was in the interests of 
scientific rigour as the Nicholas Manual Muscle tester is a validated, reliable instrument 
with a history of usage in shoulder strength measurements (Sklaar 2000).  ROM 
measurements were made in upright sitting as originally described.  Only active ROM is 
considered in the C-M scale.  
Ellenbecker (1997) recommended the use of simple goniometry plus a manual anterior 
containment force to measure shoulder range of movement.  This was not described in the 
original C-M scale, but is a reasonable precaution to take in view of the invariably 
composite nature of glenohumeral motion.  As a result, a second set of readings was 
taken in which a manual anterior containment force was applied to the affected shoulder. 
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3.10. DATA COLLECTION
Demographic data was collected as per “Patient Demographic information 
sheet” (Appendix A).   Pre- and post-intervention scores were entered on the data 
collection forms (Appendices D and E).
3.11. STATISTICAL CONSIDERATIONS
Sample size:  At the outset of the study, it was determined that for a full size study, when 
the sample size in each of the 4 groups is 16, a one way analysis of variance will have 
90% power to detect (at the 0.05 level of significance) a difference between the mean 
changes in the 4 groups anticipated to be 8;10;15 and 24 points on the modified C-M 
scale.  This calculation assumes a common standard deviation of 12.5 points.  This 
standard deviation is based on the range of possible anticipated change in the Kleinhenz 
et al study (1999).  A sample size of 20 per group was planned and would have made 
provision for a 25% drop out rate.  These sample size calculations were made using 
nQuery Advisor V5 software (Elashoff 2002).  The pilot study however utilised a sample 
size of just 20 participants. 
Data analysis: In the primary analysis, the change in C-M scores from baseline to the end 
of the study (visit 5) was compared in a one-way analysis of covariance (ANCOVA) with 
the baseline value as covariate.  In a similar way, a secondary analysis was also done by 
assessing the change within visits 1 to 4 and between visits i.e. end of previous visit and 
onset of current visit.  As data was skewed, the above analyses have been performed 
using ANCOVA for ranks followed by pair-wise comparison between groups to assess 
specific differences. Testing was done at the 0.05 level of significance.
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4.  RESULTS
4.1. GENERAL RESULTS
4.1.1.DEMOGRAPHICS
25 participants were entered into the study of which 20 completed the full study.  This 
represents a relatively high drop-out rate of 20%.  The group demographic breakdown is 
summarised in table 4.1.  The group allocation was slightly skewed as one participant was 
incorrectly randomised.  DDN=6, PDN=4, SDN=5, CON=5.
The groups were well matched regarding age and gender parameters, allowing for the 
effect of the small size.
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Table 4.1: Summary of demographic data
Summary of demographic data
Group Median Age Genderm / f
Affected side
L / R
Dominance
L / R
CON (n=5) 37 2/2 1/3 0/5
DDN (n=6) 37 1/5 1/2 2/4
SDN (n=5) 33 2/3 1/4 0/5
PDN (n=4) 36 3/1 3/1 0/4
Total n=20 Mean = 36
4.1.2. FREQUENCY AND DISTRIBUTION OF MTRPS IN MUSCLES OF THE ROTATOR CUFF
The breakdown of the incidence of involved muscles by therapeutic group is given in Table 
4.2. and Fig 4.2.
Figure 4.1:  Relative frequency of involved muscles
16%
11%
49%
24%
Supraspinatus Infraspinatus Teres Minor Subscapularis
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Table 4.2: Number of MTrPs in each muscle by therapeutic group
Number of MTrPs in each muscle by therapeutic group (n=20)
Supraspinatus Infraspinatus Teres Minor Subscapularis
CON 3 10 2 1
DDN 7 18 2 6
SDN 7 7 4 4
Placebo 5 10 2 4
Total 22 45 10 15
% Incidence 23.9 48.9 10.9 16.3
There was a greater incidence of MTrPs in the Infraspinatus muscles than in the other cuff 
muscles, with almost half of the MTrPs occurring within the Infraspinatus muscles.  The 
significance of this will be discussed below.
4.2.ADVERSE EVENTS
There were no reports of adverse events relating to the treatment modalities employed in 
the study from those who completed the study.  However, no comment can be made as to 
the incidence of adverse events among those who did not complete the study as they did 
not respond to repeated attempts to follow them up. 
4.3.RESULTS OF SPECIFIC RESEARCH OBJECTIVES
The objectives detailed in 1.6 are recapitulated below.  
Compare the changes in Constant-Murley scale scores between patients treated with the 
four interventions on a pre-trial / follow up visit basis for each group.
Compare the changes in Constant-Murley scale scores, ROM, Power in patients on a pre-
intervention / post-intervention (intra-treatment) basis at each treatment for each group. 
 Compare the changes in Constant-Murley scale scores in patients on a between 
intervention (inter-treatment) basis at each treatment for each group results of each of the 
variables were analysed accordingly.  
The significant results are summarised in 4.6.1. (Table 4.14)
In addition, in order to make direct comparisons with the comparator study (Kleinhenz et al 
1999), the mean C-M differences and standard deviations of the current study were also 
calculated.
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4.3.1.  THE CONSTANT-MURLEY SCALE
4.3.1.1.  TREATMENT EFFECT PRE & POST TRIAL: There was a highly significant 
difference between the groups when analysed over the course of the study when 
analysed by ANCOVA for ranks.  Specifically, DDN was superior to CON 
(p≤0.05), and to SDN (p≤0.02) (see Figure 4.2).
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Figure 4.2  Mean C-M score change Pre-Post trial
 CON           DDN           PDN
p≤0.05 p≤0.2
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4.3.1.2. INTRA-TREATMENT EFFECTS: There was a significant difference between the 
groups at session 3 (p<0.01) when analysed by ANCOVA for ranks.  In particular, 
this difference is explained by the difference between DDN and CON (p<0.01), 
DDN and SDN (p<0.01), and DDN and PDN (p<0.01).  In all cases DDN 
performed worse than the comparators.
4.3.1.2.1.  There was a significant difference between the groups at session 4 
(p≤0.03) when analysed by ANCOVA for ranks.  This difference is explained by 
the difference between groups DDN and CON (p<0.01), DDN and PDN 
(p<0.03).  Again, DDN performed worse than the comparators (see Figure 4.3).
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Figure 4.3:  Mean intra-treatment change: C-M 
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4.3.1.3. INTER-TREATMENT EFFECT: The groups were also analysed to see if there 
were differences that may have occurred between the treatment sessions 
regarding C-M score changes.  There was a marginally significant difference 
between the groups when the groups were analysed by ANCOVA for parametric 
data for the interval between the end of session 1 and the beginning of session 2 
(p=0.09).  This is explained by the difference between DDN and CON (p=0.03) 
and between groups DDN and PDN (p=0.08) (Figure 4.4).
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Figure 4.4:  Mean Inter-treatment changes:  C-M scores
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4.3.2.  EXTERNAL ROTATION POWER
4.3.2.1. TREATMENT EFFECT PRE & POST TRIAL:    There were no significant differences 
(p=0.46) between the groups for the pre trial-post trial interval (see Figure 4.5).
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Figure 4.5   Mean External Rotation Power change: Pre & Post trial
p=0.46
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4.3.2.2.INTRA-TREATMENT EFFECT: There was a highly significant difference between the 
groups at session 2 (p=0.036) when analysed by ANCOVA on a parametric basis.  
This difference is explained by the difference between CON and DDN (p=0.03), and 
CON and SDN (p<0.05) (Figure 4.6).
4.3.3.INTER-TREATMENT EFFECT.  There were no significant differences between the 
groups for any of the inter-treatment periods.
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Figure 4.6:  Mean External Rotation Power change:  Intra-treatment
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4.3.4.INTERNAL ROTATION POWER
4.3.4.1. TREATMENT EFFECT PRE & POST TRIAL: There were no significant 
differences (p=0.3) between the groups for the pre trial-post trial interval.
4.3.4.2.  INTRA-TREATMENT EFFECT. There were no significant differences between 
the groups for this variable.   
4.3.4.3.  INTER-TREATMENT EFFECT.  There were no significant differences between 
the groups for this variable.   
4.3.5.  EXTENSION POWER
4.3.5.1. TREATMENT EFFECT PRE & POST TRIAL: There were no significant 
differences (p=0.46) between the groups for the pre trial-post trial interval
4.3.5.2. INTRA-TREATMENT EFFECT:  There were no significant differences between 
the groups for this variable.
4.3.5.3.  INTER-TREATMENT EFFECT:  There were no significant differences between 
the groups for this variable.   
4.3.6.  ABDUCTION POWER 
4.3.6.1.  TREATMENT EFFECT PRE & POST TRIAL:  There were no significant 
differences between the groups for this variable (p=0.79).  
4.3.6.2.  INTRA-TREATMENT EFFECT:There were no significant differences between 
the groups for this variable.  
4.3.6.3.  INTER-TREATMENT EFFECT: There were no significant differences between 
the groups for this variable. 
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4.4. FLEXION RANGE OF MOTION:
4.4.1.  TREATMENT EFFECT PRE & POST TRIAL:  There were no significant differences 
between the groups for this variable (p=0.79) (see Table 4.7). All groups had mean 
end of trial readings within 7 degrees of each other despite differing baselines.
Figure 4.7:  Mean Flexion ROM change: Pre & Post trial
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4.4.2.  INTRA-TREATMENT EFFECT: There was a significant difference between the 
groups at session 2 (p=0.04) when analysed by ANCOVA for ranks.  This 
difference is explained by the difference CON and PDN (p<0.01), DDN and PDN 
(p≤.05) (see Figure 4.8).
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Figure 4.8:  Mean Flexion ROM change: Intra-treatment
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4.4.3.INTER-TREATMENT EFFECT: There were no significant differences between the 
groups for this variable. 
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4.5.INTERNAL ROTATION RANGE OF MOTION
4.5.1.TREATMENT EFFECT PRE & POST TRIAL:  There were no significant differences 
between the groups for this variable (p=0.86) (see Table 4.9).8
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Figure 4.9:  Mean Internal ROM change: Pre & Post trial
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8 The apparently larger effect in the CON group is due to to a lower mean baseline in that 
group.
4.5.1.1.INTRA-TREATMENT EFFECT: There was a highly significant difference 
between the groups at session 3(p=0.015) when analysed by ANCOVA for ranks. 
This difference is explained by the significant differences between CON and 
DDN (p≤0.05).  There were also marginally significant differences between CON 
and SDN (p=0.07), DDN and SDN (p=0.06), and DDN and PDN (p=0.07) (see 
Figure 4.10).
Figure 4.10:  Mean Internal ROM change: Intra-treatment
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4.5.1.2. INTER-TREATMENT EFFECT: There was a highly significant difference 
between the groups when analysed by ANCOVA for ranks between the 
beginning of treatment 4 and the end of treatment 3 (p=0.03).  This difference is 
explained by the differences between DDN and CON (p=0.03), DDN and SDN
(p=0.01) and DDN and PDN (p=0.02).  This same effect was marginally 
significant when analysed by ANCOVA for parametric data (p=0.88) (see Figure 
4.11). 
Figure 4.11:  Mean Internal ROM change: Inter-
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4.5.2.EXTERNAL ROTATION RANGE OF MOTION
4.5.2.1. TREATMENT EFFECT PRE & POST TRIAL:  There were no significant 
differences between the groups for this variable (p=0.75) (see Figure 4.12).
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Figure 4.12:  Mean External ROM change:  Pre & Post trial
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4.5.2.2.  INTRA-TREATMENT EFFECT: There were no significant differences between 
the groups for this variable. 
4.5.2.3.  INTER-TREATMENT EFFECT: There was a significant difference between the 
groups when analysed by ANCOVA for ranks between the beginning of treatment 
3 and the end of treatment 2 (p=0.05).  This is explained by the difference 
between DDN and SDN (p=0.08) and DDN and PDN (p<0.01) (see Figure 4.13).
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Figure 4.13:  Mean External ROM change: Inter-treatment
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4.6. SUMMARY OF SIGNIFICANT RESULTS
4.6.1. A summary of the significant results is given in Table 4.3 below.  Note that in 
each of the significant results, DDN plays a determining role in the treatment effect 
size.
Summary of the statistically significant findings
Variable
Level of 
significance
<0.05 = High
<0.1 = Marginal
Interval
Group causing 
difference
 Positive influence  +
Negative influence   -
C-M p=0.01, p=0.04 Post-Pre trial DDN + (vs SDN, CONT)
C-M p<0.00 Intra-treatment session 3 DDN -
C-M p=0.03 Intra-treatment session 4 DDN -
C-M p=0.09 Inter-treatment 2-1 DDN +
External rotation 
power p=0.04
Intra-treatment 
session 2
CON +
DDN -
SDN -
Flexion range of 
movement p=0.04 
Intra-treatment 
session 2
PDN-
DDN +
CON +
Internal range of 
movement p=0.02
Intra-treatment 
session 3 DDN +
Internal range of 
movement p=0.03 Inter-treatment 4-3 DDN +
External rotation 
range of movement p=0.05 Inter-treatment 3-2 DDN +
Table 4.3:  Summary of the statistically significant findings
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5.  DISCUSSION
The discussion that follows will expand on the primary outcome measure (C-M) results.  
The secondary outcome measures (power and range) results will also be discussed in the 
light of the C-M results.  These analyses were used to form the basis of the conclusions 
drawn.  Only the results with statistical significance will be discussed.  The significance of 
the frequency and distribution of MTrPs in the infraspinatus muscle will be assessed with 
reference to the study objectives
5.1. THE CONSTANT-MURLEY SCALE
5.1.1.TREATMENT EFFECT PRE & POST TRIAL  The DDN group showed a highly significant 
improvement over both the SDN and CON groups over the course of the study (p=0.01 for 
SDN, and p=0.04 for CON).  The DDN group in this pilot study had a mean change of 39.3 
points which was 56% greater than the mean of the other groups which were closely 
grouped (CON=26, SDN=23 and PDN=17).  The mean C-M scores were comparable for 
those groups with comparators in the Kleinhenz et al (1999) study values on a pre trial / 
post trial basis (see Table 5.1).   This was expected as this study was used as a 
methodological and statistical base for the pilot study under discussion.  There was slight 
variance (especially with the placebo groups) which may be explained by the addition of a 
common physiotherapy regime to this study, but which was absent from the comparison 
study13.  Thus the CON group did not have a comparator.  
Similarly, there was no true DDN group in the Kleinhenz et al (1999) study. The Kleinhenz 
et al (1999) study published results in terms of mean changes in C-M scores and standard 
deviations therefrom.  This comparison study showed a mean change from baseline in the 
C-M score of 19.2 points (SD 16.1, but with a wide variance (-13 to 50)) for the 
acupuncture group, and 8.37 points (SD 14.56 (-20 to 41)) for the placebo needle group.  
The comparable groups in the current study were the SDN and PDN groups.  SDN had a 
mean change of 23 points (SD 20.1(-3 to 52.76)).  This is comparable with the Kleinhenz 
et al (1999) study values.  PDN had a mean change of 17 points (SD 21.64(0-59.35)) 
which is larger than the Kleinhenz et al (1999) study but still of a similar magnitude to both 
SDN and CON. 
  The sample size of the study is not large enough to draw firm conclusions, but it seems 
there is a trend toward a larger treatment effect in the DDN group than any of the other 
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groups . This may be explained by the elicitation of LTRs from the MTrPs in the muscles 
being treated, and re-iterates the need to distinguish between acupuncture-like needling 
techniques and LTR-obtaining dry needling.  The Integrated hypothesis explanation for the 
MTrP phenomenon whereby a local hypoxia is reversed by the facilitation of local bleeding 
rather than by a neural mechanism may be supported by this result.
5.1.2.INTRA-TREATMENT EFFECTS. A non-parametric/ranked ANCOVA test revealed that there 
was a highly significant difference (p<0.00) between DDN and all of the other groups by 
the time the post-treatment observations were made. The difference is due to the relatively 
poor performance of the DDN group scores. DDN is consistently worse off immediately 
after treatment.  This may be due to pain inhibition following the local trauma caused by 
the technique, or the trauma itself ( (see Hong et al (1994b)9.  This finding is similar to 
Srbely et al (2010) who indicated that DDN PPT is transiently reduced immediately 
following needling.     
This was similarly true of the C-M results at the end of treatment 4.  Here the difference is 
again highly significant (p=0.03).  However, it must be emphasised that DDN showed a 
trend to greater clinical benefit than the others on a pre-trial/ post-trial analysis (see 5.1.1 
above) and it was anticipated that an analysis of changes in C-M scores beween 
treatments (see 5.1.3) may reveal when the clinical gains occurred.  
5.1.3. INTER-TREATMENT EFFECT: An analysis of the inter-treatment effect using the same 
statistical approach did not reveal a significant difference between the groups between the 
second, third and fourth treatment sessions as expected, but rather between the first and 
second treatments only10 .  The effect was particularly noticeable between the CON and 
DDN groups11.  
The pattern of increased clinical improvement between treatment sessions rather than 
directly after them is repeated in the analyses of changes to internal and external rotation 
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9 Hong et al (1994b) noted that patients had clinically significant pain related to the needling therapy, but also 
that the initial pain complaint was much improved by 8 hours post needling.
10 This result is slightly anomalous and may be due to the small sample size.
11 Graphically the SDN group appears to show greatest benefit in this analysis but it is an artefact of a 
variance in the base values of the groups
ranges of motion.  This accords with the proposed humoral effect of DDN where the 
inflammatory cascade and normal healing response to the intramuscular insult take days 
rather than minutes to effect a response.  This result speaks to the problems identified by 
Cummings and White (2001) above where they found no evidence of the efficacy of dry 
needling beyond that of placebo; it appears that there may well be a significant benefit in 
the use of TOIMS-type dry needling where the elicitation of a LTR is emphasised, but the 
timing of the measurements taken may play a role in the outcome of the study.  
5.2.  EXTERNAL ROTATION POWER
5.2.1.INTRA-TREATMENT EFFECTS.  There is a significant difference between CON and 
DDN (p=0.03) by the end of treatment 2, where CON has a greater effect than DDN.  
There is also a significant difference between CON and SDN (p=0.05) by the end of 
treatment 2, where SDN has a greater effect than CON.  However, there is no 
significant difference by the pre-treatment 3 observations.  This reinforces the 
observation that DDN suffers from a transient negative effect immediately post 
treatment which may be due to the pain of intramuscular needling.
5.3.  INTERNAL ROTATION RANGE OF MOTION
5.3.1. INTRA-TREATMENT EFFECTS:   There was a highly significant difference in the 
groups at pre-session 3 (p=0.02) when analysed by rank.  This difference was 
explained by the significant differences between CON and DDN (p<0.00) where DDN 
was more effective than CON.  There were also marginally significant differences 
between groups CON and SDN (p=0.07) where SDN was superior to CON, DDN and 
SDN (p=0.06) where DDN was superior to SDN, and DDN and PDN (p=0.07) where 
DDN was superior to PDN.  DDN appeared to be consistently more effective than the 
other groups in effecting an improvement in internal rotation range of motion.  This 
may be related to the high incidence of MTrPs in the infraspinatus muscle which is 
eccentrically involved in internal rotation control of the glenohumeral joint (see 5.6).  
The trend of the effect appears to reduce over the four treatment sessions as the 
participants ROM approached normal values.  CON appears to show greater 
improvement over DDN at treatment 1, but this is not a significant difference as the 
baseline values for CON were lower, giving greater potential for improvement.
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5.3.2.  INTER-TREATMENT EFFECT: The DDN effect is also reflected in the highly 
significant difference (p=0.03) between the groups between treatment sessions 4 and 
3 when the inter-treatment period was analysed.  Internal rotation range of motion of 
the glenohumeral joint is check-reined by the Infraspinatus muscle. The significance 
of this correlation is discussed in 5.7.  
5.4.   FLEXION RANGE OF MOTION
5.4.1.INTRA-TREATMENT EFFECTS: There was a highly significant difference between the 
groups at the end of session 2 (p=0.04) when analysed by rank.  This difference is 
explained by the difference between groups 1 and 4 (p<0.00), 2 and 4 (p=0.05).  
However, the difference may be due more to the poor performance of the PDN group 
than positive effects of the CON and DDN groups.
5.5. EXTERNAL ROTATION RANGE OF MOTION
5.5.1.  INTER-TREATMENT EFFECT: There was a significant difference between the 
groups when analysed by ANCOVA for ranks between the beginning of 
treatment 3 and the end of treatment 2 (p=0.05). Patients treated with DDN 
showed a greater ability to recruit the external glenohumeral rotators than the 
other groups. This may be partly explained by the high incidence of MTrPs in 
the external rotator muscle Infraspinatus (see 5.7).
5.6.  THE TIMING OF THE TREATMENT EFFECT
The effect of the time intervals between intervention and observation was not fully 
appreciated in the design of the study. There appeared to be a consistent improvement in 
the DDN variables with the majority of the treatment effect occurring before the fourth 
treatment session, but this was complicated by the observations made immediately after 
the interventions.  Srbely et al (2010) identified very short term reductions in pressure point 
sensitivity (<10 minutes) after single episodes of intramuscular needling of MTrP-like 
entities which they refer to a secondary loci of hyperalgesia.  They hypothesised that a 
greater effect would be seen if mutiple loci were needled at repeated interventions.  The 
results reported herein indicate that this may be true, and that only three deep needling 
sessions may be required to show the majority of the clinical improvements when using 
DDN12.  However, from this study, it does not appear to be helpful to analyse the effect of 
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the intervention immediately subsequent to it.  Srbely et al (2010) strongly advocated a 
neurogenic model, and did not address local biomechanical issues.  Although this study 
did not address pressure point sensitivity, other cardinal signs of MTrPs were assessed. 
Patient reported pain was transiently lessened in the SDN group, correlating with Srbely 
(2009).  This was not seen in the DDN group. The effect of the elicitation of multiple LTRs 
through DDN is to cause local tissue trauma and bleeding, and this appears to negate 
some of the immediate reduction in pressure point sensitivity; the C-M scores were 
consistently worse immediately after treatment compared to pre-treatment levels, but 
showed a significantly better result a few days later.
Range of motion is one of the parameters affected my MTrPs (see Table 1.1).  Huguenin et 
al (2005) discussed above used a single-intervention method to investigate the effect of 
needling on MTrP’s in the gluteal muscles but did not find evidence that needling affected 
the range of hip flexion, which could be interpreted as evidence against the contention that 
DDN of MTrPs results in ROM increases. However, it appears from the current study that 
more than one needling session is required to see clinical change, but that the greatest 
proportional changes will seen before the third session.  It may follow that just two to three 
sessions of DDN may be needed.
5.7.  THE SIGNIFICANCE OF THE RELATIVE INCIDENCE OF MTRPS
This pilot study was not designed to investigate the incidence of MTrPs in the rotator cuff.  
Anecdotally, however, both research assistants independently reported that they 
experienced a greater number of LTRs from the infraspinatus muscle than the other 
muscles. This accords with literature reviewed above which identified a key role for the 
infraspinautus muscle in RCS.  The co-incidence of rotator cuff symptoms which may be 
potentially linked to the functions of the infraspinatus muscle (decreased lateral rotation 
power and reduced medial rotation range of motion) with a high proportion of MTrPs in the 
Infraspinatus muscles is noted. 
The co-incidence appears to warrant further investigation, and an examination of the 
relative contribution of each muscle of the rotator cuff to the RCS symptoms should be 
incorporated in the design of a full size study.
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5.8. LIMITATIONS OF THE STUDY
The known effect of supraspinal changes in chronic MPS has not been controlled for, and 
no accounting has been made for any concomitant psychological issues (see Niddam 
2009).  The study is also limited by its small size.  However, the study was conducted as a 
pilot study with the aim of which was to identify which would be the most effective dry 
needling technique to investigate rotator cuff pathology in a larger study.  This size of the 
treatment effect differences between the control and placebo groups and the active 
needling groups seems to indicate that these groups could be disposed of in a larger study 
with greater statistical powering. 
It is possible that patients were misdiagnosed using the Hawkins-Kennedy and Neer’s 
tests given the complex nature of glenohumeral biomechanics; scapula positioning was 
not controlled for (Lewis 2009).  However, the study attempted to reflect common practice 
in making the diagnosis, and was not designed to discuss the validity of the tests used.
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Comparison of C-M scores between reference study and this one
Group C-M change (this study) C-M Change (Kleinhenz)
CON 26
DDN 39,3
SDN 23 19.2
PDN 17 8.37
Table 5.1  Comparison of C-M scores between reference study and this one
6.CONCLUSION
The aim of this pilot study was to investigate the relative effects of three different forms of 
dry needling and a common physiotherapy protocol on the symptoms of a rotator cuff 
syndrome.  The results indicate that a there may be a significant benefit to the use of DDN 
in such patients when compared to either conventional physiotherapy, superficial dry 
needling, or placebo needling, as measured by changes in the Constant-Murley scale, 
glenohumeral external rotation power, and in glenohumeral internal rotation range of 
motion.   
The maximum benefit from DDN appears to peak after the second treatment.  The effect 
may be due to humoral mechanism. Consequently, greater subtlety regarding the timing of 
the measurements taken will be required in a fully powered study.   It is proposed that just 
two or three sessions of DDN may be required as part of an integrated therapeutic 
approach to RCS.
 The co-incidence of multiple infraspinatus MTrPs and beneficial improvements in 
glenohumeral function specifically related to the infraspinatus muscle bears further 
investigation.
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Appendix A: Demographic data collection form
  
These details will be kept separate from any other information 
generated in this study.
Name:______________________________________________________________
Age (as of 1 May 2005) ________Years  Male/ Female (Circle appropriate)
Home address:____________________________________
  ____________________________________
  ____________________________________
  ____________________________________
Postal address:_____________________________________
  _____________________________________
  _____________________________________
Telephone numbers:  (h)_____________________________
            (w)_____________________________
            (cell)____________________________
Medical history: Smoker Y/ N     How many per day?_______
What medicines are you currently taking?
________________________________________________________________________________
__________________________________________________________
Please circle if any of these conditions apply to you:
Pregnant Previous shoulder surgery Had physio for shoulder in past month
Have had any form of needle therapy  Haemophilia  Needle phobia
Miscellaneous: 
1. Are you currently under any treatment for your shoulder pain?
a. If so, what treatment?  ________________________________________
Office use only
Informed consent form  ٱ     Inclusion criteria ٱ   Exclusion criteria ٱ   RA N    ٱ
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Appendix B: Patient information sheet
!
“A comparison of dry needling and myofascial 
release therapy using a single blind, placebo 
controlled, randomised control trial”
Hello. 
 My name is Bruce Barker.  I am a physiotherapist and am currently conducting physiotherapy 
research for a Masters degree in physiotherapy.
In my study, I want to see what things physiotherapists can do to help people like you with shoulder 
problems get better quicker.  I am particularly interested in seeing whether very thin needles can be 
used to help fix shoulder problems.  This is what the experiment you are being asked to participate 
in is about; “Does the use of dry needling work to help people with shoulder pain?”
It is a scientific study.  The University of the Witwatersrand’s (WITS) Ethical committee has given 
me permission to carry it out.  The Physiotherapy department, which is part of the WITS Faculty of 
Health Sciences (Medical School), is supervising the study.
What I am asking you to do for me is to voulenteer to take part in the study; you are under no 
obligation to do so. This means that if you voulenteer, you will be put into one of 4 groups, and 
your shoulder will be treated according to a set procedure that I have developed.  Neither you nor I 
will know which group you are in.  You will be treated 4 times, once every three days, and then 
come in for a check up without treatment 1 month after the last treatment. This is a total of 5 visits.  
Each treatment visit will take 30 minutes, but the last one only 15 minutes.
Not all the groups will have exactly the same treatment, but everyone will get effective treatment.  
All the treatments will be carried out by a qualified physiotherapist who has also been specially 
trained in dry needling treatments.  All participants will receive “normal physiotherapy”.  This 
“normal physiotherapy” treatment will consist of gentle heating, some easy-to-do shoulder 
exercises, tight muscle releases, and joint movements.  All of these should be pain free. In addition 
to this normal treatment, three of the groups will also have some form of needle treatment.  One 
group will have needles put into muscles, and one group will have needles put into skin.  These 2 
groups will feel some discomfort during treatment.  The third group will be treated with a newly 
designed placebo needle.  You will not feel this needle as it only pretends to pierce the skin.  Group 
4 will be treated with normal physiotherapy only.  All participants will have easy but important 
exercises to do at home.
A summary of these groups is in the table on the next page.
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Group 1 Group 2 Group 3 Group 4
Gentle heating over 
the shoulder
Easy-to-do shoulder 
exercises
Tight muscle 
release
Shoulder joint 
movements
Home exercises
Gentle heating over 
the shoulder
Easy-to-do shoulder 
exercises
Tight muscle 
release
Shoulder joint 
movements
Needle treatment 
into the muscles 
(slight discomfort)
Home exercises
Gentle heating over 
the shoulder
Easy-to-do shoulder 
exercises
Tight muscle 
release
Shoulder joint 
movements
Needle treatment in  
the skin (slight 
discomfort)
Home exercises
Gentle heating over 
the shoulder
Easy-to-do shoulder 
exercises
Tight muscle 
release
Shoulder joint 
movements
Needle treatment 
(will not feel the 
needles)
Home exercises
The technique is safe, but there are still a few things you need to know about the needling part of 
the treatment.  You may experience an aching feeling for 24 hours after the treatment, as you would 
with any injection.  This goes away, and doing the exercises helps a lot to ease the discomfort.  You 
may have a small bruise, or you may feel quite tired.  These are temporary.  There is also a very 
small chance that a needle may puncture your lung if the wrong technique is used.  However, the 
study is designed with maximum safety in mind to minimise these risks and side effects.
The experiment will last for 2 weeks, and you will need to come every three days for treatment.  Do 
not forget about the follow up 3 months after this treatment period.  I need you to keep all the 
appointments or I cannot use your results.  You are however free to tell me you want to stop being a 
part of the experiment at any time, and you do not have to give me a reason unless you want to.  
Your privacy and anonymity will be maintained at all times
Please sign the attached consent form only if you have asked any questions you want to, are happy 
with the answers, and are happy to voulenteer to be part of the study.
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Appendix C: Patient consent form
!
Patient Consent form
“A comparison of dry needling and myofascial 
release therapy using a single blind, placebo 
controlled, randomised control trial”
I, …………………………………………………………………………………………..
hereby agree to be part of the physiotherapy experiment called “A comparison of dry needling and 
myofascial release therapy using a single blind, placebo controlled, randomised control trial”.
I have read and understood everything in the information sheet provide to me.
I have had the opportunity to ask any questions that I want to, and have been given satisfactory 
answers.
I understand that I can withdraw from this study at any time.
I understand that my private details will be kept private, and not shared with any third party.
Signed:………………………………………………..       Date:  ……………………..
Randfontein
Witness: …………………………………………              Date: ……………………...
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Appendix D: Pre-intervention Constant-Murley Scale 
Data collection form
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Appendix E: Post-intervention Constant-Murley Scale 
Data collection form
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Appendix F: Shoulder assessment tool
RAN:  …………………..      Date:  …/…/……
Occupation:  ……………………….
Sports/  Hobbies:  ………………………………
Dominant arm:  R L   Painful shoulder:  R L
History of shoulder pain:  
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………
Previous medical history:
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
Aggravation factors:
………………………………………………………………………………………………
Mitigation factors: 
………………………………………………………………………………………………
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Posture type:
    Ideal
    Flat back
    Sway Back
    Upper cross
    Kyphosis-Lordosis
Appendix G: Shoulder exercises
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Please do 3 sets of each of these exercises, and 
repeat this 3 times per day
Appendix H: Photographs of the cuff muscles being 
needled
F1:  Subscapularis (0.35x75mm)
F2:  Supraspinatus (0.3x50mm)
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F3:  Infraspinatus (0.3x25mm)
F4:  Teres Minor (0.3x30mm)
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Appendix I:  Results of ANCOVA of Treatment effect Part 1
90
Outcome Analysis p - Parametric p - Ranked
C-M Sess1diff\Sess1 0,3386 0,2497
C-M Sess2diff\Sess2 0,3869 0,183
C-M Sess3diff\Sess3 0,0716 0,0044
C-M Sess4diff\Sess4 0,0319 0,0303
C-M Final-Pre 0,9789 0,0695
abdpow Sess1diff\Sess1 0,7042 0,7928
abdpow Sess2diff\Sess2 0,5645 0,4359
abdpow Sess3diff\Sess3 0,1379 0,4454
abdpow Sess4diff\Sess4 0,5094 0,5769
abdpow Final-Pre 0,7971 0,7836
abdrom Sess1diff\Sess1 0,5107 0,617
abdrom Sess2diff\Sess2 0,4452 0,2278
abdrom Sess3diff\Sess3 0,9707 0,7187
abdrom Sess4diff\Sess4 0,8048 0,7227
abdrom Final-Pre 0,7802 0,8661
extpow Sess1diff\Sess1 0,4612 0,8615
extpow Sess2diff\Sess2 0,6845 0,5544
extpow Sess3diff\Sess3 0,1682 0,091
extpow Sess4diff\Sess4 0,1877 0,2873
extpow Final-Pre 0,464 0,4181
flexpow Sess1diff\Sess1 0,8283 0,9178
flexpow Sess2diff\Sess2 0,1933 0,4221
flexpow Sess3diff\Sess3 0,7263 0,8268
flexpow Sess4diff\Sess4 0,4195 0,7972
flexpow Final-Pre 0,0696 0,1131
Appendix I: Results of ANCOVA of Treatment effect Part 2
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Outcome Analysis p - Parametric p - Ranked
irotpow Sess1diff\Sess1 0,752 0,4412
irotpow Sess2diff\Sess2 0,9122 0,8995
irotpow Sess3diff\Sess3 0,6059 0,5122
irotpow Sess4diff\Sess4 0,4979 0,8633
irotpow Final-Pre 0,3045 0,2254
xrotpow Sess1diff\Sess1 0,5283 0,7384
xrotpow Sess2diff\Sess2 0,0356 0,1268
xrotpow Sess3diff\Sess3 0,4188 0,7281
xrotpow Sess4diff\Sess4 0,0737 0,3969
xrotpow Final-Pre 0,7926 0,5138
xrotrom Sess1diff\Sess1 0,5398 0,4254
xrotrom Sess2diff\Sess2 0,6421 0,6039
xrotrom Sess3diff\Sess3 0,8149 0,7655
xrotrom Sess4diff\Sess4 0,6671 0,6364
xrotrom Final-Pre 0,7483 0,1935
Irotrom Sess1diff\Sess1 0,7653 0,6271
Irotrom Sess2diff\Sess2 0,399 0,1614
Irotrom Sess3diff\Sess3 0,0645 0,0149
Irotrom Sess4diff\Sess4 0,8015 0,8567
Irotrom Final-Pre 0,8601 0,9351
flexrom Sess1diff\Sess1 0,7283 0,5915
flexrom Sess2diff\Sess2 0,2836 0,04
flexrom Sess3diff\Sess3 0,1397 0,281
flexrom Sess4diff\Sess4 0,4025 0,2968
flexrom Final-Pre 0,7927 0,3853
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Outcome Analysis p - Parametric p - Ranked
CM Begin 2-End 1 0,0944 0,1569
CM Begin 3- End 2 0,7627 0,4355
CM Begin 4 - End 3 0,9659 0,9194
CM Follow -End 4 0,8954 0,9917
AbdPow Begin 2-End 1 0,5945 0,8319
AbdPow Begin 3- End 2 0,6694 0,8094
AbdPow Begin 4 - End 3 0,7544 0,8708
AbdPow Follow -End 4 0,6162 0,737
AbdRom Begin 2-End 1 0,5904 0,435
AbdRom Begin 3- End 2 0,2662 0,454
AbdRom Begin 4 - End 3 0,9045 0,9648
AbdRom Follow -End 4 0,9698 0,9248
ExtPow Begin 2-End 1 0,9182 0,7039
ExtPow Begin 3- End 2 0,2483 0,2198
ExtPow Begin 4 - End 3 0,9614 0,5856
ExtPow Follow -End 4 0,4801 0,4866
FlexPow Begin 2-End 1 0,8464 0,7247
FlexPow Begin 3- End 2 0,2017 0,2373
FlexPow Begin 4 - End 3 0,3746 0,6027
FlexPow Follow -End 4 0,8296 0,9971
IrotPow Begin 2-End 1 0,3725 0,3409
IrotPow Begin 3- End 2 0,9699 0,9964
IrotPow Begin 4 - End 3 0,7952 0,8396
IrotPow Follow -End 4 0,2666 0,1016
XrotPow Begin 2-End 1 0,4739 0,4702
XrotPow Begin 3- End 2 0,1082 0,2616
XrotPow Begin 4 - End 3 0,3535 0,437
XrotPow Follow -End 4 0,8219 0,5912
XrotRom Begin 2-End 1 0,3838 0,7573
XrotRom Begin 3- End 2 0,047 0,0501
XrotRom Begin 4 - End 3 0,7454 0,7937
XrotRom Follow -End 4 0,7242 0,1703
IrotRom Begin 2-End 1 0,5619 0,1042
IrotRom Begin 3- End 2 0,6273 0,2855
IrotRom Begin 4 - End 3 0,0882 0,0331
IrotRom Follow -End 4 0,9801 0,7383
FlexRom Begin 2-End 1 0,3289 0,3445
FlexRom Begin 3- End 2 0,3361 0,1095
FlexRom Begin 4 - End 3 0,4811 0,5684
FlexRom Follow -End 4 0,9573 0,9361
Appendix J: Results of ANCOVA of Inter-treatment 
Appendix K: Ethical clearance.
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